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Dehydration has many deleterious effects ranging from impaired cognitive function to 
decreased aerobic performance. This study evaluated the effects of a mild, passive dehydration 
on the transcriptional responses of circulating immune cells. We pursued research questions 
about how whole-body dehydration and small changes in plasma osmolality may affect the 
greater concept of immune resiliency or susceptibility to infection through acute gene expression 
changes that may persist during chronic stress. Our approach was to precisely quantify 
hypertonicity experienced by circulating peripheral blood mononuclear cells and neutrophils and 
quantify transcriptomic changes in cell lysates using RNAseq. RNAseq revealed 373 total genes 
changing significantly in the level of expression following a 24-hour fluid restriction protocol in 
18 male subjects (23±3.28 years, 80.09±9.6 kg, 175.78±5.68 cm). Upregulated biological 
process GO Terms included coagulation, humoral immune response, granulocyte activation, 
neutrophil-mediated immunity, and regulation of body fluid levels. Downregulated biological 
process GO Terms included response to interferon-gamma, interferon-gamma-signaling 
pathway, innate immune response, and lymphocyte mediated immunity. Further research should 
be done on specific genes within the set to determine their candidacy as novel biomarkers related 
























LITERATURE REVIEW AND INTRODUCTION 
 Much is known about conserved cell volume responses and cellular responses to 
hypertonic stress in cell culture and renal tissue models [1]. However, there is little known about 
how subtle shifts in osmolality affect circulating immune cells, the surveillance system and often 
first-line defense against infection. We pursue research questions about how whole-body 
dehydration and small changes in plasma osmolality may affect the greater concept of immune 
resiliency or susceptibility to infection through acute gene expression changes that may persist 
during chronic stress. Our approach is to precisely quantify hypertonicity experienced by 
circulating peripheral blood mononuclear cells and neutrophils and quantify transcriptomic 
changes in cell lysates using RNAseq. This brief literature review outlines current understanding 
in 4 areas: whole body dehydration effects on plasma osmolality, how endocrine regulation (in 
circulation) regulates plasma osmolality, current understanding of cellular response to osmotic 
stress, and cellular damage experienced during osmotic/hypertonic stress. 
1. Whole body dehydration results in increased plasma osmolality 
Hypohydration is a state in which body water deficit is greater than normal daily 
fluctuation (typically >2% of body mass loss) [2]. Dehydration (i.e., losing water) is the process 
that results in hypohydration. The degree of dehydration is measured indirectly by acute changes 
in body mass, plasma osmolality, plasma volume, urine color, and urine output [3, 4]. Changes to 
hydration state can modify vascular fluid compartments [5].  Plasma osmolality increases with 
dehydration [6-8]. Plasma osmolality (Posm) is well correlated with changes in acute body mass 
loss as a result of dehydration. A -1% ∆BM is significantly related to increased serum osmolality 
in individuals exercising in the heat [9]. Subjects exercising at -2.5% of their euhydrated body 
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mass had significantly higher serum osmolality than a control group that drank to replace sweat 
loss and maintain euhydration [10]. Posm is also sensitive to acute rehydration in dehydrated 
individuals, and significantly changes within 30 minutes of fluid repletion [6]. During a passive 
fluid restriction protocol, Posm increases relative to time spent in a hypohydrated state [11]. 
Dehydration due to passive dehydration, exercise, and exercise heat stress decrease plasma 
volume as a result of sweating and further stimulate the hormonal response to plasma osmolality 
[12-16]. The sensation of thirst is a reproducible effect of hyperosmolality [17, 18]. Posm 
hyperosmolality that correlates to <2% loss of body water triggers the sensation of thirst and the 
release of AVP. As plasma osmolality increases, the sensation of thirst increases linearly [19]. 
Plasma osmolality decreases within minutes following consumption of water [20]. 
2. Endocrine regulation of plasma osmolality 
Changes in Posm and plasma volume are detected by specialized central and peripheral 
osmoregulatory neurons [21], and arterial baroreceptors [22]. Reductions in plasma volume are 
sensed by arterial baroreceptors located primarily in the pulmonary, renal, and carotid arteries. 
Following a hypovolemic stimulus, renin release acts to increase the circulating concentration of 
angiotensin II, promoting vasoconstriction and an increase in blood pressure [19]. Peripheral 
osmoreceptors detect acute changes in Posm after digestion, and afferent pathways to the central 
nervous system produce anticipatory responses to keep Posm within a homeostatic range [23]. Acute 
hyperosmotic stress stimulates sympathetic nervous system activity and increase plasma 
norepinephrine [24, 25]. Central osmosensitive neurons synapse in the paraventricular nucleus of 
the hypothalamus [26]. The PVH plays a pivotal role in the hypothalamo-pituitary-adrenocortical 
axis, itself a key component in the response to homeostatic stress. Following challenges to osmotic 
stress, arginine vasopressin (AVP), also known as anti-diuretic hormone (ADH), is released from 
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the posterior pituitary. AVP originates in the hypothalamus, as the preprohormone 
prepropressophysin [27]. Prepropressophysin is cleaved in the hypothalamus to produce a 
prohormone, which is cleaved again in secretory vesicles to AVP en route to the posterior pituitary. 
AVP acts on V1 receptors in smooth muscle, promoting vasoactivity, and on V2 receptors in renal 
cells, signaling water channels (aquaporins) to move to the cell surface and exert an antidiuretic 
effect [28]. Figure 1 [29] shows the cellular mechanism by which AVP acts in renal cells. In 
homeostatic conditions, aquaporins are stored in vesicles in renal collecting duct cells. Following 
AVP activation of V2 receptors, a secondary messenger cascade beginning with membrane-bound 
G-proteins promotes the phosphorylation and translocation of aquaporin channels to the apical 
membrane [29]. In situations of high plasma osmolality, water passively moves out of the 
collecting duct down the osmotic gradient. Decreases in blood volume further increase sensitivity 
to AVP [17, 30].   
   
Figure 1: Model of the regulation of water permeability in renal collecting duct cells [29] 
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3. Subtle plasma osmolality increases can induce cellular changes 
Cells are sensitive to changes in osmotic pressure. Acute changes in osmolality can 
influence cell size and shape, cell machinery is compromised in the presence of osmotic stress 
[31, 32], DNA breaks increase, and the cell cycle is stopped [33]. Cells counter the hostile 
environment by accumulating organic osmolytes and increasing heat shock protein expression.  
If the environment proves too hostile, apoptosis occurs [34]. Thus, the range of osmotic 
pressures to which cells are exposed are tightly regulated. Regardless of how well plasma 
osmolality is protected, cells are nevertheless exposed to subtle changes in the tonicity of their 
environment. 
In hypertonic environments, water follows the osmotic gradient out of the cell via 
aquaporins. The accumulation of solutes unable to cross the cell membrane exerts an osmotic 
stress on the cell, and if left unchecked, can lead to cell death. Thus, cells require mechanisms by 
which to counter these potentially deadly effects. These mechanisms can take place from in a 
matter of seconds to over the course of days. Renal cells are exposed to large fluctuations in 
osmolality, and thus are great candidates for studies of cellular response to hypertonic stress. The 
osmolality of the inner medullary region of the kidney can reach 1,200 mOsm⋅kg-1 in humans 
[35, 36]. During periods of dehydration, NaCl and urea are accumulated in the medulla to 
reabsorb water. When there is a surplus of total body water, solute concentration in the medulla 
decrease, limiting the water pulled out of the collecting duct and resulting in a diluted urine [18]. 
The change in solute concentration in the medulla exposes renal cells to a very wide range of 
osmotic pressure, and present renal cells with several challenges. Na+ and Cl- cannot pass 
through the cell membrane and exerts a very large osmotic stress on the cell. Urea, while it can 
enter the cell on its own and thus creates less of an osmotic stress, disrupts cell function and 
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protein structure in high intracellular quantities. The extreme and sudden osmotic fluctuations to 
the extracellular environment require effective movement of osmolytes into and out of the cell. 
Almost immediately, intercellular ion concentration increases to draw water back into the cell, a 
process referred to as regulatory volume increase (RVI) [33, 37-40]. RVI is mainly mediated by 
hypertonicity-induced cation channels (HICCs). Sodium, chloride, and potassium transport 
across the cell membrane is mediated by the Na+/K+/2Cl- co-transporter, Na+/H+ exchanger, 
and the Cl-/HCO3- exchanger. The following increase in ionic strength within the cell, while 
successful in drawing water into the cell, is not conducive to normal cell function. Acute 
increases in intracellular concentration of Na or urea produces rapid arrest of the cell cycle, 
Figure 2: Schematic of cellular adaptation to hypertonic stress. Adapted from Alfieri et al. [40] 
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giving cells time to adapt to the change in environment by accumulating intracellular osmolytes 
compatible with cell function. The rate of proliferation decreases as osmolality increases [41].  
4. Cells respond to hypertonic stress-induced reductions in volume and DNA and protein 
damage 
  Osmotic stress causes protein damage [42, 43]. Cell shrinkage associated with water 
loss promotes protein aggregation, which is toxic to cells[44]. Regions of proteins which 
normally are hidden to the environment of the cell become exposed and can interact with other 
proteins. Hypertonicity promotes upregulation of protein chaperones, proteins which act to 
preserve the normal orientation of other proteins in stressful environments.  Following a 
disturbance to osmotic homeostasis, RVI is mediated by ion transport into the cell. The 
subsequent intracellular increases in NaCl concentration cause DNA double strand breaks [45]. 
DNA damage is the driving force behind cellular adaptation to osmotic stress [46]. If the damage 
is not corrected in a reasonable amount of time the cell undergoes apoptosis [33, 38, 47, 48]. 
Strand breaks are detected by complex cellular machinery, and are rapidly repaired when NaCl 
concentration decreases [48]. Mediator of DNA damage checkpoint 1 (MDC1) protein and the 
Mre11-Rad50-Nbs1 (MRN) protein complex are key proteins in the strand break surveillance 
mechanism. MRN recruits elements responsible for the activation of tonicity response element 
binding protein (TonEBP) [46]. TonEBP is further activated by dimerization, which allows for 
increased phosphorylation during hypertonic stress, and the hypertonic environment itself. 
TonEBP activation stimulates multiple pathways including those responsible for heat shock 
protein synthesis and transcription of genes responsible for organic osmolyte transporters [49]. 
Organic osmolytes such as sorbitol, myositol, amino acids, and amino acid derivates normalize 
the tonicity of the intercellular environment and total cell volume, and do not disrupt cell 
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function even in high concentrations [50, 51]. Heat shock proteins (HSP) are connected to the 
DNA damage response. HSP expression is upregulate following cellular exposure to a DNA 
damaging agent. HSP70 has been shown to facilitate the removal of damaged pyramidine 
nucleotides [52]. DNA damage sensor ataxia telangiectasia and Rad3-related protein (ATR) is a 
client protein of the 90Kda heat shock protein HSPC1 (HSP90). Inhibition of this heat shock 
protein has been shown to decrease the damage response following a DNA double strand 
break[53].  
 
RESEARCH AIM and HYPOTHESIS 
 The research aim of this study was to use RNAseq to quantify the genome-wide 
transcriptional changes that occur in circulating immune cells exposed to small shifts in plasma 
osmolality due to whole body dehydration. Our hypothesis was that despite much smaller 
magnitude of changes associated with gene transcription changes observed in cell culture or 
renal tissue, circulating immune cells exhibit acute changes in gene expression that reflect a 
stress response. We hypothesized that upregulated genes would include genes important for 
cytoprotection or immune activation and downregulated genes would include constitutively 
expressed genes important for normal cellular growth and function. 
 
METHODS 
An outline of the study design is provided in figure 3. 18 male subjects (23±3.28 years, 
80.09±9.6 kg, 175.78±5.68 cm) participated in this study. Subjects were required to report to the 
Human Performance Laboratory eight times over the course of 4 days- twice on Days 1 and 3, 
three times on Day 2, and once in the morning of Day 4. Morning visits were to be prior to any 
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consumption of food or fluid. Subjects were asked to record all dietary intake and collect all 
urine produced for each 24-hour period of the study (Day 1-Day2, Day2-Day3, etc.), and refrain 
from alcohol consumption and exercise.. At all visits, subjects provided a urine sample and a 
blood sample from an antecubital vein. Blood used for RNA sequencing was collected in 
PaxGene® tubes and stored according to manufacturer guidelines prior to analysis.  
 
 
On the morning of Day 1, baseline information for height, weight, urine color and 
osmolality, and plasma osmolality was collected. Subjects were asked to eat and drink as normal 
during Day 1, and returned to the HPL in the afternoon. After visiting the HPL on the morning of 
Day 2, subjects were asked to refrain from consuming water or any beverage for a full 24 hours. 
Figure 3: Study design. 2TH represents the onset of thirst, and as such did not occur at the same time for all 
subjects. Timepoints used for RNA analysis are highlighted in green 
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Subjects were asked to return to the HPL as soon as possible after they noticed feeling thirsty for 
the first time that day. Following the morning visit on Day 3, subjects were allowed 30 minutes 
of ad libitum fluid consumption in the HPL, after which another blood draw was performed. 
Following this, subjects asked to return to their normal dietary intake of food and fluid for the 
following 24 hours before returning to the HPL on the morning of Day 4. At this point, 
participation in the study was concluded. All subjects were consented according to the University 
of Connecticut institutional review board guidelines.  
Hydration state measurements 
Plasma and urine osmolality were analyzed in duplicate using freezing point depression 
(Advanced Instruments OsmoPro). Urine specific gravity was assessed using a hand-held 
refractometer. Urine color was compared to a validated urine color chart [54]. A repeated 
measures analysis of variance (SPSS 26) was used to analyze the differences across timepoints 
for body mass, 24-hour urine specific gravity, urine osmolality, urine color, and plasma 
osmolality. ANOVA revealed significant group by time interaction with respect to plasma 
osmolality (F=4.960, p<0.00001, observed power=.996), 24h urine specific gravity (F=3.856, 
p=0.002, observed power = .959), body mass (F=12.561, p < 0.0001, power = 1.0), urine 
osmolality (F=12.457, p<0.0001, observed power =.993), and urine color (F=11.156, p<0.0001, 
power =.987). 
Statistical Analysis 
Based on a similar study conducted previously in our laboratory [55], the variation (SD) 
in body mass loss during a similar fluid restriction period was 0.8%, and the day-to-day between-
subject variation was ~50%.  In the proposed research, we anticipate the smallest change in body 
weight will be 1.5%. We selected an effect size (ES) of 0.2, (i.e., the smallest effect size worth 
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detecting according to Cohen’s effect size statistics). The maximum chance of a Type 1 error 
was set at 5% (very unlikely), and the maximum chance of a Type 2 error was set at 20% 
(unlikely). For the present experimental design, which has a pre- and post-dehydration weight 
measurement for each subject, the minimal sample size to detect a significant difference (i.e., p < 
0.05) was computed as n=12. 
RNASeq Analysis 
A timeline of the study indicating the timepoints used for RNA seq analysis is contained 
in figure 3, indicated by the green DNA icons. Raw genome reads were trimmed with Sickle 
[56], with a quality threshold of 30 and length threshold of 45, following that the trimmed reads 
were mapped to Homo Sapiens genome (GRCh38 ensembl release 99) with HISAT2 (version 
2.1.0) [57]. The resulting SAM files then converted into BAM format using samtools (version 
1.9) [58], and the PCR duplicates were removed using PICARD [59]. The counts were generated 
against the features with htseq-count [59]. The differential expression of genes between 
conditions were evaluated using DESeq2 [59]. Covariates were introduced in the DESeq2 
analysis to increase the accuracy of results, and genes showing less than 10 counts across the 
compared samples were dropped from the analysis. Results are reported with the baseMean 
(counts of the gene normalized for the total number of samples), log2FoldChange (the effect size 
estimate reported on a logarithmic scale with base 2), lfcSE (the standard error of the effect size). 
Genes with a false discovery rate (FDR) < 0.05 were considered to be significant and used in the 
downstream analysis. Upregulated and downregulated genes were grouped into gene ontology 





Individuals became significantly dehydrated during the fluid restriction protocol  
Average body mass decreased by -1.8 ± 1.1% after 24h fluid restriction compared to the 
1AM timepoint (, p <0.0001) (figures 6 and 7). 24h urine specific gravity and osmolality were 
significantly increased during the fluid restriction protocol (USG: D1-D2 1.016 ± 0.007, D2-D3 
1.024 ± 0.004, p<0.0001; Urine Osmolality: D1-D2 589.43 ± 258.14 mOsm/kg, D2-D3 890.63 ± 
159.85 mOsm/kg, p<.01). Urine color rating significantly increased during the 24h fluid 




















Figure 5: plasma osmolality fold change by timepoint 
Figure 4: Plasma osmolality increases significantly during the 24h passive dehydration protocol. 
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Figure 6: Body mass significantly decreases during the 24h passive dehydration. 
 
Figure 7: body mass losses approached 2% of total body weight at the end of the passive dehydration protocol. 
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Figure 8: Urine specific gravity was significantly higher during the 24 hours of fluid restriction 
 
Figure 9: Urine color was significantly darker during the 24 hours of fluid restriction 
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Figure 10: urine osmolality was significantly higher during the 24 hours of fluid restriction 
Immune cells in circulation experienced significant osmotic stress  
Plasma osmolality measurements are contained in figures 4 and 5. Plasma osmolalities 
between at euhydrated timepoints 1AM (293.94 ± 4.74 mOsm/kg) and 2AM (294.32 ± 6.28 
mOsm/kg) were not statistically different (p=.831). Plasma osmolality was significantly 
increased during the 2PM and 3AM timepoints compared to the 1AM baseline (2PM 298.87 ± 
4.67 mOsm/kg, p<.05; 3AM 297.40 ± 5.16 mOsm/kg, p<.05).  
Gene expression was altered in response to dehydration 
WEBGESTALT GOSlim analysis for both upregulated and downregulated genes is 
contained in figures 11a and 11b. Out of 276 total upregulated genes 7.97% were related to 
granulocyte activation, 6.15% to regulation of body fluid levels, 6.52% to the humoral immune 
response, and 7.60% to neutrophil-mediated immunity. Of the 161 downregulated genes, 9.93% 
 16 
were related to the innate immune response, 5.59% to the response to IFN-gamma, 4.34% to 
IFN-gamma signaling, and 4.96% were related to lymphocyte mediated immunity. 
 
 
Figure 11a: WEBGESTALT GOSlim analysis for upregulated genes 
 
 




The protocol was sufficient to cause the subjects to become dehydrated. Plasma 
osmolality significantly increased from baseline to the 3AM timepoint, and based on the 
significant changes to gene expression, it is evident that this shift was sensed by peripheral blood 
mononuclear cells (PBMCs) and neutrophils in circulation. A sufficient level of dehydration was 
further evidenced by the changes in body mass, urine specific gravity, urine color, and urine 
volume.  
 This study is the first of its kind examining the gene expression of circulating immune 
cells exposed to subtle shifts in plasma osmolality. An increase in ~5 mOsm·kg-1 was enough to 
elicit significant changes in gene expression. A full list of genes with significantly changed 
levels of expression, both upregulated and downregulated, is included in Appendix A. Following 
24 hours of fluid restriction, 378 genes were significantly different in their expression.  
Upregulated Genes 
 The small increase in plasma osmolality was enough to cause an upregulation in several 
categories of Gene Ontology terms (GO terms). Those categories related to pathways responsible 
for regulation of body fluid, neutrophil-mediated immunity, and granulocyte activation are 
discussed, although DAVID analysis indicated 29 unique biological process GO terms were 
upregulated (Appendix B, Table 4). 
Genes involved in the regulation of body fluid levels were primarily related to smooth 
muscle contraction. This is likely indicative of compensatory vasoconstriction in response to 
dehydration, increasing plasma volume. It is worth noting that 1 gene which coded for aquaporin 
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10 was upregulated, although over-representation analysis (ORA) enrichment via 
WEBGESTALT did not include it in this category. 
The transcriptional response to dehydration indicated an upregulated immune response 
with regard to granulocytes, specifically neutrophils, a component of the humoral immune 
response. Dehydration is sensed at a cellular level as a hyperosmotic stress, and if left 
uncorrected, can trigger an inflammatory response. Inflammation is a natural adaptive response, 
typically mediated by the immune system, and allows cells and tissues to maintain homeostasis 
despite unfavorable conditions [60]. Inability to sense extracellular hyperosmotic stress, or 
mount an appropriate inflammatory response, can lead to a variety of pathologies. Diabetes, 
arthritis, cardiovascular diseases, liver diseases, and retinopathies are all linked to dehydration 
and hyperosmotic stress [61]. A brief overview of selected upregulated GO terms related to 
immune function follows. 
Granulocytes are the most abundant leukocytes in the blood [62] and are distinguished 
morphologically by presence of granules. Granulocytes have been shown to be resistant to 
dehydration [63]. Tsuchida et al. found that a 3-day dehydration in a mouse model induced 
granulocyte number and granulocyte production of superoxide. Production of superoxide by 
granulocytes is assoicated with tissue damage following extreme periods of dehydration [63].  
Neutrophil activity increases following dehydration after exercise [64]. Dehydration leads 
to increased plasma catecholamines [63, 65], which further modulates the immune response [66]. 
Chishaki et al. found that neutrophil count increased by almost 80% following judo practice in 
which participants were severely dehydrated [67]. Neutrophil count and activity were greater in 
dehydrated individuals following moderate exercise in hot environments [68].  
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One pathway within the upregulated gene list that we find particularly interesting for 
future research is that of CD9, one of its ligands, member of the integrin beta family, and the 
relationship to coagulation and immune system activation. In our GO analysis, we identified that 
many individual genes are identified in 5 pathways associated with immune regulation, 
coagulation, and fluid regulation (Appendix C, Tables 7-12). This pathway serves as an example 
of a relatively unstudied pathway in cellular hydration and whole body dehydration physiology 
and promising new area of biomarker discovery and mechanistic research. CD9 has been 
demonstrated in a few studies to be transcriptionally responsive to extreme hypertonic stress 
interventions [69]. Sheik-Hamad et al. demonstrated that CD9 is not only transcriptionally 
upregulated 3.3-fold in response to a 200mOsm/kg change in osmolality in cell culture but also 
reduced with the addition of protective organic osmolytes such as betaine. Additionally, CD9 is 
known to be a receptor for IL-16 [70], a pro-inflammatory cytokine which has been 
demonstrated to increase significantly in exercise and environmental stress protocols [71], but 
has not been explored specifically. We propose from our findings that this is one example of a 
novel pathway to further examine cellular resilience to dehydration, exercise, and environmental 
stress. 
Downregulated Genes 
Our broad overview analysis of downregulated genes (Appendix D, Tables 13-16) 
indicates that many of the downregulated genes are related the major histocompatibility complex 
(MHC) found in antigen presenting cells. MHC molecules are divided into two subcategories, 
class I and II, and both are responsible for presenting antigens and foreign peptides on their 
surface for recognition by cytotoxic T lymphocytes. The adaptive immune response is based on 
this interaction. The functional pathways in which the altered genes exist appear to be heavily 
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reliant on interferon gamma, with two of the identified GO terms being response to interferon 
gamma and interferon gamma signaling pathway. 
IFN-γ performs its biological function through the IFN-γ receptor-mediated transduction 
pathway, and one of its many anti-pathogenic functions is the upregulation of MHC I expression 
on the cell surfaces[72, 73]. Cells incubated in media containing IFN-γ have increased MHC I 
expression versus cells in control media[73]. IFN-γ is the only interferon that can promote the 
expression of MHC II in antigen presenting cells, and can also induce MHC II gene expression 
in cells that do not typically express MHC II [74]. Downregulation of these genes relating to 
antigen presentation indicates a suppression of the adaptive immune response following 
dehydration. The complicated nature of our downregulated genes requires further analysis and 
study in our ongoing research. 
PRACTICAL APPLICATION AND CONCLUSION 
 This study is the first of its kind to use RNA sequencing to identify potentially novel 
biomarkers related to thirst and whole-body dehydration. The size of this data set makes these 
results particularly unique, as there is no other study to date that has looked at dehydration-
induced transcriptome changes using this many subjects. This data elucidates the complexity of 
the cellular responses to a mild dehydration and provides a springboard from which researchers 
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Appendix A: RNAseq results 
 
Table 1: All genes with significantly different levels of expression following the 24 hour fluid restriction 
Gene Name baseMean log2FoldChange lfcSE stat pvalue padj 
AOC1 13.2594648 1.474050991 0.428985875 3.43612943 0.00059009 0.02695455 
TMEM176A 175.75525 1.524019395 0.312454164 4.87757749 1.07E-06 0.000165194 
CYP26B1 4.97314721 7.724582872 1.6057956 4.81043968 1.51E-06 0.000218281 
PGLYRP1 258.627824 1.66861291 0.278994731 5.98080437 2.22E-09 6.69E-07 
CD9 104.384725 1.387009999 0.249178686 5.56632682 2.60E-08 6.33E-06 
STAB1 708.338558 1.752974158 0.306291774 5.72321657 1.05E-08 2.81E-06 
TSPAN9 26.1037821 1.267813811 0.381174288 3.3260738 0.00088079 0.034396293 
SLC11A1 2712.29715 1.036257755 0.229689116 4.51156665 6.44E-06 0.000782274 
ADGRA2 28.2940504 1.096505061 0.38816836 2.82481823 0.00473074 0.09495505 
SH3YL1 148.208022 -1.249930197 0.187599971 -6.6627419 2.69E-11 1.31E-08 
MYOM2 138.098539 3.252654966 0.418801 7.76658835 8.06E-15 6.75E-12 
TNFRSF9 61.2996965 1.026779208 0.29701459 3.45699923 0.00054623 0.025413015 
HOMER3 47.9458245 1.183508961 0.343467788 3.44576407 0.00056945 0.026281788 
ENTPD2 12.1369914 3.263791092 0.728784064 4.47840623 7.52E-06 0.000883494 
VASH1 131.434195 1.466952178 0.245641388 5.97192593 2.34E-09 6.93E-07 
FCGR2B 232.101751 1.32525201 0.17399204 7.61673932 2.60E-14 2.06E-11 
PANX2 222.719958 1.004722453 0.257314896 3.90464162 9.44E-05 0.006938828 
MGLL 97.4352203 1.518614469 0.253251953 5.99645708 2.02E-09 6.20E-07 
RAP1GAP 10.5134469 -1.991495376 0.637443495 -3.1241912 0.00178295 0.054405099 
RAPGEF3 23.5667175 1.091356722 0.36598784 2.98194804 0.00286421 0.071478982 
DDX43 8.05222558 -2.020060047 0.711611025 -2.8387138 0.00452958 0.092682993 
COL5A3 66.7351813 1.52026625 0.286655121 5.30346795 1.14E-07 2.48E-05 
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CTTN 30.9433437 1.261407614 0.379388721 3.32484216 0.00088469 0.034459322 
GNA11 31.0518915 1.040415399 0.330613915 3.14691957 0.00165 0.051601975 
SMOX 139.880631 1.443235936 0.421496125 3.42407878 0.00061689 0.027511716 
RPH3A 88.5143747 3.034673968 0.297489988 10.2009281 1.96E-24 5.92E-21 
PUS7 39.9430989 2.68494883 0.304515307 8.81712271 1.17E-18 1.77E-15 
NRCAM 20.8508692 -1.937561083 0.499396164 -3.8798077 0.00010454 0.007348388 
ITGA6 277.157866 -1.036383542 0.252483463 -4.1047581 4.05E-05 0.003610073 
DSP 18.4050665 7.417222387 1.49147201 4.97308856 6.59E-07 0.000107967 
TPTEP1 51.7839587 1.664128214 0.296933508 5.60438001 2.09E-08 5.34E-06 
BIK 11.0837612 2.293904293 0.660280128 3.47413801 0.0005125 0.024447421 
PVALB 4.28940047 2.610832413 0.865043699 3.01815089 0.00254322 0.066556483 
GZMH 553.486952 -1.02632427 0.328341048 -3.1257873 0.0017733 0.054220468 
MMP9 728.808312 1.257378263 0.239697878 5.24567959 1.56E-07 3.26E-05 
CTSZ 2223.31135 1.303120565 0.215723643 6.04069423 1.53E-09 5.14E-07 
NTSR1 15.9192874 1.485702527 0.438236843 3.39018171 0.00069846 0.029910889 
MYL9 146.89307 2.68284514 0.663908716 4.04098497 5.32E-05 0.004558786 
BMX 30.5139435 1.120504411 0.347822086 3.22148724 0.00127527 0.044395938 
PCYT1B 5.77712393 2.928473284 0.946055876 3.09545489 0.00196511 0.0579689 
NECAB2 62.2930721 1.521064001 0.431480397 3.52522157 0.00042313 0.021768745 
RETN 52.8786028 1.71707899 0.426902753 4.0221783 5.77E-05 0.004723928 
TNNT1 19.3264322 2.198986133 0.582692711 3.77383498 0.00016076 0.010355781 
ADAP1 137.577509 1.004972361 0.337863713 2.97449038 0.00293476 0.072522166 
TMEM176B 414.672113 1.853373093 0.307331573 6.03053267 1.63E-09 5.36E-07 
CNTNAP3 52.4554446 1.329391283 0.431076051 3.08389037 0.00204313 0.059312559 
PRUNE2 15.3608566 1.521198691 0.495035046 3.07291111 0.00211982 0.060441279 
NPDC1 108.070995 1.103057067 0.339169708 3.25222755 0.00114504 0.040998528 
NEURL1 78.7058583 1.30012609 0.284011987 4.57771555 4.70E-06 0.000595463 
KRT23 182.373838 1.191902292 0.234989397 5.0721535 3.93E-07 6.98E-05 
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RUNDC3A 199.196964 1.745850437 0.60436215 2.8887488 0.00386778 0.084090664 
P2RX1 532.646935 1.114600641 0.206393783 5.40035957 6.65E-08 1.52E-05 
FOLR3 249.093949 -2.735306657 0.30619774 -8.933138 4.14E-19 8.27E-16 
VWF 31.9923714 1.709331052 0.419373537 4.07591539 4.58E-05 0.004016843 
VNN1 115.504766 1.140816149 0.28699667 3.97501528 7.04E-05 0.005496522 
PDGFRB 33.6187278 1.342468582 0.397116634 3.38053979 0.00072344 0.030376252 
CEP70 10.16909 -2.003897232 0.659778928 -3.0372253 0.00238767 0.064577936 
TP53I3 34.0432776 1.116308493 0.338939952 3.2935288 0.00098938 0.037454584 
HSPE1 11.1859989 -1.957932055 0.671243706 -2.9168721 0.00353561 0.07978404 
PLCL1 31.0975482 -1.040830476 0.335734967 -3.1001551 0.00193419 0.057506959 
PADI2 1378.36863 1.845555484 0.188907323 9.7696344 1.52E-22 3.82E-19 
PILRB 110.243916 1.719551675 0.285377516 6.02553311 1.69E-09 5.41E-07 
RASL11A 23.6922764 1.12752416 0.393972094 2.86193915 0.00421058 0.089394709 
PHF24 12.9201279 2.301308355 0.56287645 4.08847866 4.34E-05 0.003827663 
SARDH 36.6080126 1.162446153 0.381182813 3.04957651 0.00229164 0.063436422 
ENKD1 47.5916999 1.079554573 0.311837196 3.46191726 0.00053634 0.025108135 
PI3 656.51376 2.852823318 0.386477306 7.3816063 1.56E-13 1.07E-10 
DOK4 32.1392494 1.098935109 0.32040699 3.42981003 0.000604 0.027341609 
PZP 14.2720663 -1.911523831 0.605643055 -3.1561888 0.00159845 0.05094099 
SRD5A3 27.5975792 1.043485136 0.365588103 2.85426448 0.00431366 0.090436879 
GNAZ 46.1131603 1.402704874 0.409245798 3.42753641 0.00060908 0.02740699 
LRRC6 39.743579 2.449597543 0.394867151 6.2035992 5.52E-10 2.03E-07 
CDKN1C 35.7565519 1.746284636 0.444534901 3.92834091 8.55E-05 0.006382862 
GADD45G 8.46259282 2.285092438 0.651997498 3.50475645 0.00045703 0.022587532 
IQCN 115.846263 1.047409361 0.240897493 4.34794628 1.37E-05 0.001448561 
LRP3 60.0865504 1.268726744 0.365342841 3.47270181 0.00051525 0.024501074 
NAPSB 619.180656 1.962607227 0.290907543 6.74649825 1.51E-11 7.87E-09 
ENOSF1 143.181808 -1.018122395 0.273414995 -3.7237255 0.0001963 0.012329549 
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RAMP1 8.24784177 2.808676165 0.882753892 3.18172051 0.00146403 0.048933019 
JCHAIN 190.149036 2.069305128 0.438051765 4.72388264 2.31E-06 0.000322952 
IGHMBP2 213.722182 1.027819518 0.191675292 5.36229531 8.22E-08 1.82E-05 
CHIT1 22.9565618 1.551882692 0.460510397 3.3699189 0.0007519 0.031052568 
TMTC1 22.4485241 1.144384013 0.367360482 3.11515275 0.0018385 0.055538078 
CTIF 14.0755194 1.431252977 0.509135326 2.81114451 0.00493656 0.097400155 
GSTM1 49.1359819 1.019251191 0.338921117 3.00734047 0.00263544 0.067792977 
RSAD2 112.233194 -1.214574318 0.231620486 -5.2438122 1.57E-07 3.26E-05 
SPOCD1 21.489969 1.800911396 0.601678217 2.99314708 0.00276117 0.069835275 
BORA 24.0436989 -1.196067806 0.422492609 -2.8309792 0.00464057 0.093895304 
MYCBPAP 6.22424239 -4.147383865 1.168919933 -3.5480479 0.0003881 0.020313141 
ERMN 54.4527233 -1.064689741 0.344989144 -3.0861543 0.00202764 0.059119106 
BLK 94.8777949 1.205871029 0.292181166 4.1271347 3.67E-05 0.003295744 
DAB2IP 6.57825246 2.164794772 0.695968002 3.11048032 0.00186783 0.055864526 
TUBB2A 81.3852019 4.604814892 0.532232209 8.65189068 5.07E-18 6.36E-15 
IFI44 102.833594 -1.126625094 0.31323264 -3.5967679 0.0003222 0.017777926 
B4GALNT3 63.1635801 1.487699122 0.346975173 4.28762412 1.81E-05 0.001814853 
KIF21A 35.9566422 -1.087397431 0.364518251 -2.9831083 0.00285337 0.071478982 
HDC 99.9418564 1.265360962 0.329653774 3.83845435 0.00012381 0.008478784 
KIFC3 56.2448831 1.233701154 0.312193104 3.95172455 7.76E-05 0.006028824 
IFITM3 1478.86024 1.546341239 0.317246795 4.8742533 1.09E-06 0.000166302 
ZNF787 174.966842 1.006147395 0.306780387 3.27969922 0.00103918 0.038582688 
ZNF614 52.897518 -1.032872193 0.314873675 -3.2802748 0.00103706 0.038582688 
FCRL5 208.281554 1.819489833 0.212727296 8.55315639 1.20E-17 1.39E-14 
AQP10 17.0027138 2.534267669 0.665744769 3.80666554 0.00014085 0.009274864 
GDF7 20.1793779 -1.435687785 0.491947773 -2.9183744 0.00351862 0.079633212 
ETAA1 33.8854162 -1.431171832 0.419606169 -3.4107502 0.00064784 0.028471144 
THNSL2 24.0088464 2.441300342 0.469493147 5.19986363 1.99E-07 3.96E-05 
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USP53 67.570782 -1.072069263 0.358166938 -2.9932111 0.00276059 0.069835275 
TMEM209 47.9758831 -1.053522005 0.357575543 -2.9462921 0.00321609 0.075748855 
CHST7 75.1321163 1.204733897 0.287783717 4.1862476 2.84E-05 0.002671904 
GRIK4 16.1513864 2.528106505 0.523889124 4.82565182 1.40E-06 0.000206227 
PLCH2 54.0343188 -1.61057401 0.408827538 -3.9394949 8.17E-05 0.006255968 
ESAM 54.3572373 1.708685077 0.385824012 4.42866442 9.48E-06 0.001066636 
TAGLN 260.037973 -1.155600556 0.20744222 -5.5707105 2.54E-08 6.33E-06 
ALDOA 84.312674 1.619014621 0.42189616 3.83747181 0.00012431 0.008478784 
PRSS23 98.9152175 1.151720324 0.322173616 3.57484371 0.00035044 0.018866035 
SPEF2 30.8363048 -1.1051585 0.379991404 -2.9083776 0.00363309 0.080655741 
CLEC4F 17.6097593 4.474027386 0.625356797 7.15435957 8.41E-13 5.28E-10 
GPR15 24.4335167 -1.285553651 0.422387617 -3.0435401 0.00233812 0.064081568 
PGM5 28.8185383 2.324789289 0.496240795 4.68480083 2.80E-06 0.000387543 
CFAP161 5.91880441 2.157603533 0.751763551 2.87005606 0.00410399 0.087699251 
CPA5 9.95164981 2.282618369 0.679938265 3.3570965 0.00078766 0.032033977 
HTR6 9.32266657 -4.357882863 0.940330653 -4.6344154 3.58E-06 0.000477496 
CDA 737.062091 1.171409091 0.290132872 4.0374918 5.40E-05 0.004601039 
NAE1 80.3460695 -1.300588001 0.416027303 -3.1262083 0.00177076 0.054220468 
SPON2 734.976749 1.115876842 0.318319186 3.50552807 0.0004557 0.022587532 
TPPP3 69.8729606 1.266444417 0.375341845 3.37410932 0.00074055 0.03074525 
CPAMD8 64.1278729 1.003863672 0.296669898 3.38377328 0.00071497 0.030359043 
GATD3A 19.37976 2.393376977 0.476530454 5.02250581 5.10E-07 8.84E-05 
ICOSLG 10.8277074 -2.873559661 0.74671727 -3.8482566 0.00011896 0.0082258 
S100B 60.6625586 -2.931489912 0.557540987 -5.2578913 1.46E-07 3.14E-05 
SHKBP1 2416.44899 1.043306004 0.243682428 4.28141666 1.86E-05 0.001853875 
LMNA 118.017928 1.328465845 0.32093059 4.13941795 3.48E-05 0.003142867 
PPP1R35 57.550073 1.062309029 0.374698416 2.83510413 0.00458108 0.093414113 
SH2B2 171.490359 1.230058579 0.294595008 4.17542235 2.97E-05 0.002750623 
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TREML1 124.935517 1.144935679 0.335273238 3.4149331 0.00063798 0.028318131 
SLC1A7 28.7840034 1.687755744 0.479225527 3.52184024 0.00042856 0.021855933 
KIAA1522 19.8462419 1.545232957 0.416023905 3.71428886 0.00020378 0.01249752 
ALPL 1866.77209 1.212709884 0.245699345 4.93574733 7.98E-07 0.00012804 
HAAO 48.4168066 1.013459216 0.345749939 2.93119131 0.00337665 0.077616305 
PTPN13 24.9313333 -1.550552609 0.444516527 -3.4881776 0.00048632 0.023496349 
CXCL5 8.14767985 2.071600747 0.702452229 2.94909841 0.00318702 0.075748855 
PPBP 157.414238 1.349565014 0.38594409 3.49678892 0.00047089 0.0230463 
PF4 273.057628 1.43193829 0.328043424 4.36508763 1.27E-05 0.001378043 
CXCL1 31.5863319 -1.118357532 0.36218683 -3.0877918 0.0020165 0.059013851 
ERAP2 474.581193 1.348362729 0.213435295 6.31743089 2.66E-10 1.08E-07 
SHROOM1 33.336861 1.145341247 0.404159826 2.83388198 0.00459863 0.093548943 
KIAA1324L 30.2294694 -1.564821691 0.411431163 -3.8033621 0.00014275 0.009355414 
SLC13A4 30.9757276 -1.15876617 0.353879606 -3.2744644 0.00105862 0.039016406 
METTL27 4.63585109 2.49430352 0.869482316 2.86872254 0.00412133 0.087871219 
ARHGAP12 71.4988372 -1.016276218 0.315723206 -3.2188835 0.00128691 0.044647181 
LRR1 24.553472 -1.393534054 0.458114486 -3.0418904 0.00235097 0.064217686 
TMEM63C 40.0281866 1.574312087 0.364773185 4.31586573 1.59E-05 0.00165272 
ZNF503 6.3979253 2.167213992 0.765079969 2.83266336 0.0046162 0.093779728 
ARHGEF40 626.058021 1.419040057 0.198580472 7.14591943 8.94E-13 5.39E-10 
UBTD1 84.1217302 1.081258742 0.309763534 3.49059403 0.00048195 0.023435109 
CKB 28.8721275 1.52266532 0.430224983 3.53923036 0.0004013 0.020738923 
PLD4 215.672964 1.018769202 0.309923267 3.28716593 0.00101201 0.038137667 
MS4A14 125.068658 1.124372963 0.225119844 4.99455288 5.90E-07 0.000101017 
NKX3-1 51.2661846 -1.988326117 0.384569395 -5.1702661 2.34E-07 4.46E-05 
CA4 99.0674267 1.196136301 0.306871507 3.89784087 9.71E-05 0.007033627 
TMC4 7.18569199 2.88043667 1.008176303 2.85707635 0.00427563 0.090015145 
PPP1R14A 11.8807694 1.958768865 0.677582539 2.89081957 0.00384239 0.083997259 
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RILP 87.9765607 1.162595144 0.394586749 2.94636134 0.00321537 0.075748855 
TRPV3 7.44854795 2.31307759 0.783533692 2.95210993 0.00315611 0.075748855 
KRT1 135.613373 1.547059693 0.399786729 3.86971247 0.00010896 0.00760426 
EVPL 11.4367104 1.928193967 0.543981747 3.54459314 0.00039322 0.020439281 
FTH1 986.15826 1.532075329 0.419262679 3.65421347 0.00025797 0.015174846 
NT5DC2 50.3960517 1.185318521 0.331345974 3.57728361 0.00034718 0.01875786 
RNASE2 171.688383 1.301885786 0.404109801 3.22161398 0.00127471 0.044395938 
PCBP1 79.9687816 1.261489 0.409494242 3.08060253 0.00206582 0.059541496 
GP9 74.6960209 1.826347245 0.544197064 3.35604024 0.00079067 0.032039165 
MYO7B 101.571437 1.635285223 0.265401498 6.16155235 7.20E-10 2.53E-07 
MZB1 174.328519 1.089458067 0.367914034 2.96117562 0.00306467 0.074631432 
KRT72 119.067756 1.697669484 0.259910963 6.53173481 6.50E-11 3.06E-08 
PTCRA 42.1008146 1.635210169 0.538135771 3.03865726 0.00237635 0.064426449 
KNDC1 23.7027295 1.738506159 0.415882411 4.18028297 2.91E-05 0.002709101 
PWWP2B 155.844808 1.002810972 0.297082699 3.37552801 0.00073674 0.03074525 
CYP4F22 19.2658839 1.574650655 0.499006558 3.15557106 0.00160184 0.050941292 
THEMIS 39.0882417 -1.433167612 0.338717598 -4.2311578 2.32E-05 0.002261017 
LRRN3 97.2226026 -1.120743634 0.355022746 -3.1568221 0.00159499 0.050938192 
ABLIM3 39.7652498 1.567368394 0.456448368 3.43383503 0.00059511 0.027101607 
C1QA 27.097909 1.503458099 0.45387203 3.31251542 0.00092461 0.035464568 
CCR9 20.0117734 1.196171562 0.40880993 2.92598461 0.00343368 0.078542157 
LRFN4 21.746719 1.453785926 0.476921068 3.04827366 0.0023016 0.06354277 
PHOSPHO1 1934.01789 1.177599184 0.324918966 3.62428577 0.00028976 0.016515371 
PELI3 63.4751197 1.00876014 0.27778088 3.63149595 0.00028178 0.016150563 
RIN1 61.5251388 1.034058801 0.303019754 3.41251283 0.00064367 0.028393154 
CHST2 247.804704 1.155899909 0.215128754 5.37306095 7.74E-08 1.74E-05 
TP53I11 563.601709 1.124287117 0.189563374 5.93093008 3.01E-09 8.73E-07 
SPHK1 39.9278962 1.06752582 0.362202395 2.9473185 0.00320543 0.075748855 
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BOK 36.0160986 1.322831929 0.424603642 3.11545121 0.00183664 0.055538078 
BASP1 1473.74636 1.19592035 0.247535381 4.83131076 1.36E-06 0.000202435 
CRACR2B 22.4982219 1.549695799 0.553093005 2.80187199 0.0050807 0.099205331 
CD151 212.881919 1.994596039 0.320301025 6.22725462 4.75E-10 1.79E-07 
ODF3B 186.504204 1.124039453 0.38093952 2.95070318 0.00317051 0.075748855 
LRRC75B 10.678909 1.608971092 0.565260192 2.84642562 0.00442131 0.091590615 
AL162457.1 11.2659723 -2.014305717 0.704221464 -2.8603299 0.004232 0.089504478 
HLA-DQB1 650.866394 -8.719055586 1.048338279 -8.3170249 9.02E-17 8.50E-14 
LYNX1 33.1633398 1.034209957 0.351261101 2.94427693 0.0032371 0.076006349 
FZD2 41.814348 1.163870963 0.341441054 3.40870247 0.00065273 0.028602314 
CUEDC1 251.577836 1.111446899 0.214333283 5.18560107 2.15E-07 4.22E-05 
PLCXD1 172.013151 -1.051127203 0.188825058 -5.5666722 2.60E-08 6.33E-06 
CRIP2 65.0132741 1.189507177 0.340466147 3.4937605 0.00047627 0.023233867 
SPNS2 23.4448991 1.371543098 0.432408307 3.17187037 0.00151461 0.049849717 
AFMID 35.4656138 1.000670374 0.325760855 3.07179441 0.00212776 0.060516769 
BEGAIN 21.298677 1.821108701 0.3681015 4.94730041 7.52E-07 0.000121969 
PCBP3 22.591583 1.168709308 0.414639578 2.81861494 0.00482313 0.096169208 
ASCL2 56.628866 1.38359386 0.427736637 3.23468635 0.00121776 0.043015487 
KREMEN1 230.06802 1.208613024 0.24261634 4.98158131 6.31E-07 0.000104469 
PNMA3 98.2252686 -2.610848979 0.294512109 -8.8649971 7.65E-19 1.28E-15 
FAM3B 5.05724662 4.655294706 1.198051382 3.88572208 0.00010203 0.007288827 
CLDN5 16.6471787 1.76807986 0.543545946 3.25286183 0.00114249 0.040998528 
TACSTD2 10.2590396 2.763115408 0.65790848 4.19984769 2.67E-05 0.002532191 
IL3RA 173.939752 2.233669925 0.266536402 8.38035597 5.28E-17 5.68E-14 
RGPD2 6.89333993 3.230493333 0.789738888 4.09058409 4.30E-05 0.00381539 
GAS2L1 93.9893737 1.706879263 0.354406614 4.81616086 1.46E-06 0.000214177 
ADARB2 16.0694759 -7.818504879 1.492212863 -5.2395372 1.61E-07 3.28E-05 
IFIT1 181.399007 -1.220652501 0.248606789 -4.9099725 9.11E-07 0.000143448 
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KRT73 28.6165619 1.168332759 0.368024541 3.17460557 0.0015004 0.049598849 
1-Mar 119.703506 1.138078673 0.231910459 4.90740555 9.23E-07 0.000143448 
CEACAM19 22.8362654 1.261193587 0.424774687 2.96908838 0.00298685 0.073209314 
MST1L 4.31670565 -3.208622241 1.059476552 -3.0284976 0.00245773 0.065687626 
TNFRSF18 34.1996245 1.887667831 0.485171769 3.89072068 9.99E-05 0.007174286 
RHD 44.6483113 -1.015055843 0.313627614 -3.2365002 0.00121005 0.042918386 
LILRA5 295.138392 1.127571334 0.277103227 4.06913823 4.72E-05 0.004111573 
PEAR1 22.3064995 1.33345034 0.390778267 3.41229401 0.00064419 0.028393154 
ANKRD34B 8.91390722 -2.770547267 0.932185849 -2.9720975 0.00295773 0.0727321 
DRICH1 5.81115732 -2.676409611 0.851827883 -3.1419606 0.00167821 0.052169111 
KAZN 45.7917811 1.075119493 0.313921271 3.42480613 0.00061524 0.027511716 
HLA-DRB1 806.205067 -2.065593639 0.359363325 -5.7479256 9.03E-09 2.57E-06 
PRTN3 15.7653874 -2.914684126 0.957433972 -3.0442665 0.00233248 0.064081568 
C20orf204 9.15579314 1.896588955 0.599149564 3.1654683 0.00154834 0.050407058 
HLA-DQA1 650.529431 -5.82954084 0.341724048 -17.059206 2.99E-65 2.25E-61 
KIAA1671 42.6201257 -1.058732675 0.315358649 -3.3572337 0.00078727 0.032033977 
SLC25A29 245.394126 1.269883144 0.205722206 6.17280541 6.71E-10 2.41E-07 
LYPD2 23.2244885 3.126751379 0.668107511 4.68001232 2.87E-06 0.000393099 
HLA-DRB5 303.436724 -5.116132189 0.794548948 -6.4390397 1.20E-10 5.49E-08 
MMP17 100.6464 1.185222121 0.305290005 3.88228275 0.00010348 0.007323307 
COLGALT2 15.3550219 2.954478435 0.670643995 4.40543486 1.06E-05 0.001161599 
SHISA4 54.6549231 1.741524638 0.514067177 3.38773747 0.00070472 0.030008196 
GGTA1P 28.3599803 2.082816103 0.546935124 3.80815935 0.00014001 0.009274864 
TAP2 4.29238861 6.637181924 1.685807842 3.9370928 8.25E-05 0.006278909 
AGPAT1 12.3554138 -6.732666692 1.519312577 -4.4313901 9.36E-06 0.001061159 
HLA-C 2563.64945 5.433579612 0.198276615 27.4040365 2.45E-165 3.70E-161 
LILRB3 612.767142 1.067023376 0.177941564 5.99648196 2.02E-09 6.20E-07 
FAM153CP 11.4799709 2.305559152 0.529441661 4.35469915 1.33E-05 0.001414512 
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LINC01291 47.9605655 -8.390768947 1.469698146 -5.7091784 1.14E-08 3.00E-06 
MROH6 19.517688 1.356033639 0.457084735 2.96670078 0.00301014 0.073541026 
CD177 26.4100031 1.906711783 0.583687205 3.26666709 0.00108822 0.039814959 
FAM71F2 21.8591988 1.337551128 0.429138981 3.11682506 0.0018281 0.055446242 
HBM 380.084321 2.193852223 0.721361922 3.04126425 0.00235587 0.064217686 
HCP5 49.5219513 -5.815165603 0.794625242 -7.3181234 2.51E-13 1.65E-10 
HLA-H 6.18873189 5.591811816 1.545856216 3.61729102 0.0002977 0.01680737 
IGKC 3130.71934 1.512661633 0.312067275 4.84722929 1.25E-06 0.000188723 
IGKV4-1 195.18647 1.269121022 0.295833491 4.28998427 1.79E-05 0.001807724 
IGLV4-69 29.2735012 1.716241942 0.468528719 3.66304535 0.00024923 0.014849641 
IGLV8-61 28.1624064 1.618335257 0.425141419 3.80658102 0.0001409 0.009274864 
IGLV1-47 38.9438056 1.448834015 0.381212487 3.80059433 0.00014435 0.009419583 
IGLV7-46 21.1370091 2.137566671 0.586787099 3.64283175 0.00026966 0.015633774 
IGLV7-43 7.57021029 2.281714615 0.783490745 2.91224195 0.00358845 0.080115101 
IGLV2-23 76.4799088 2.440983439 0.353806753 6.89919968 5.23E-12 3.03E-09 
IGLV2-14 93.0209661 2.029622137 0.273520667 7.42036116 1.17E-13 8.38E-11 
IGLV3-12 14.0443417 4.262298188 0.770064088 5.53499151 3.11E-08 7.45E-06 
IGLV2-11 57.2827447 1.718656281 0.33283276 5.16372332 2.42E-07 4.56E-05 
IGLC2 496.144016 1.361363159 0.365784305 3.72176483 0.00019784 0.012336955 
IGLC3 276.846258 1.705917513 0.391111919 4.3617119 1.29E-05 0.001379632 
TRGC1 137.722371 -1.035743943 0.237400572 -4.3628536 1.28E-05 0.001379632 
TRGV9 53.4065378 -2.238114651 0.390269434 -5.7347936 9.76E-09 2.68E-06 
TRBV20-1 29.9890143 1.827668282 0.395386375 4.62248675 3.79E-06 0.000501365 
TRBV28 16.4397119 -2.108893287 0.521175122 -4.0464197 5.20E-05 0.00447973 
TRAV8-3 29.2365694 -1.105095279 0.333500091 -3.3136281 0.00092094 0.035413865 
TRDV2 85.5566333 -2.398909418 0.375620493 -6.3865243 1.70E-10 7.52E-08 
IGHA2 87.7692689 2.42917713 0.526182085 4.61660934 3.90E-06 0.000511285 
IGHG4 42.1442957 3.036602185 0.670718969 4.52738379 5.97E-06 0.000731866 
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IGHG2 227.698736 1.626897834 0.365696031 4.44877083 8.64E-06 0.000993769 
IGHA1 643.706474 2.236228597 0.368977427 6.06061085 1.36E-09 4.65E-07 
IGHG1 681.98212 1.883850341 0.363727306 5.17929314 2.23E-07 4.30E-05 
IGHV3-33 25.0740727 1.567585684 0.463622384 3.38116911 0.00072178 0.030376252 
IGHV4-39 27.8675925 3.2342556 0.475906308 6.79599228 1.08E-11 5.79E-09 
STARD10 169.244722 1.293785171 0.323708312 3.99676228 6.42E-05 0.005116887 
MEG3 28.056331 4.432139571 0.506394136 8.7523517 2.09E-18 2.86E-15 
RPL13P12 204.154958 2.680238008 0.574379652 4.66631782 3.07E-06 0.00041643 
GOLGA8B 200.669385 -1.438328287 0.303808609 -4.7343237 2.20E-06 0.000309632 
MYL5 66.8614947 1.007845748 0.300678037 3.3519101 0.00080256 0.032347061 
BCORP1 58.7522012 -1.737882862 0.331469392 -5.2429663 1.58E-07 3.26E-05 
C6orf226 30.8680774 1.363218758 0.485240966 2.80936453 0.00496394 0.09781234 
CEBPD 596.102999 1.18450185 0.258165024 4.58815772 4.47E-06 0.000571247 
FXYD7 13.9430715 1.748342981 0.577898534 3.02534594 0.00248349 0.065792816 
HBD 169.656105 1.489538256 0.387853551 3.8404657 0.0001228 0.008452531 
LINC00937 52.6287927 1.432394227 0.36717252 3.90114769 9.57E-05 0.006971741 
AC005082.1 6.44256664 -3.60446028 1.010506767 -3.5669828 0.00036112 0.019371707 
TRGC2 190.860015 -1.319877166 0.257295227 -5.129816 2.90E-07 5.27E-05 
NBPF13P 5.84834473 7.297412107 1.662895105 4.38837789 1.14E-05 0.00124742 
AC138969.3 7.19674786 3.596822264 1.183480442 3.03919029 0.00237215 0.064426449 
CYP4F29P 67.0239467 4.746676568 0.531741299 8.92666523 4.39E-19 8.27E-16 
ORM1 59.5753637 1.775103391 0.444028495 3.99772404 6.40E-05 0.005116887 
NAMPTP1 134.880833 6.129666517 0.557700204 10.9909705 4.22E-28 2.12E-24 
RPL10P6 47.9001424 -6.726811816 0.893608419 -7.5276952 5.16E-14 3.89E-11 
LINC01001 42.4325132 1.381917479 0.432631164 3.19421622 0.00140211 0.047658288 
AC005392.2 42.344355 8.464017984 1.475973918 5.73453086 9.78E-09 2.68E-06 
AC104809.2 60.7747713 1.397444737 0.378261981 3.69438328 0.00022042 0.013343887 
EIF3FP3 64.6606268 1.30737082 0.32407866 4.03411574 5.48E-05 0.00462914 
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DDX11L10 36.2646643 2.011402445 0.437665982 4.59574774 4.31E-06 0.000555548 
RPL10P9 218.429683 -4.388516889 0.411221508 -10.671905 1.38E-26 5.19E-23 
CCT6P3 36.8809231 -1.052327239 0.345101399 -3.0493277 0.00229354 0.063436422 
SMIM1 60.4431567 3.020917067 0.756036692 3.99572812 6.45E-05 0.005116887 
AP001189.1 65.2596979 3.19133423 0.47345986 6.74045363 1.58E-11 7.93E-09 
MAP3K2-DT 16.6695106 2.106288658 0.460969538 4.5692578 4.89E-06 0.000614836 
LINC00649 202.293852 -1.118696645 0.249091605 -4.4911054 7.09E-06 0.000847667 
DEFA3 319.872874 1.327938926 0.329255278 4.03315911 5.50E-05 0.00462914 
IGKV1-17 17.1410283 1.890426365 0.522914373 3.61517385 0.00030015 0.016820838 
IGKV1-16 31.5108611 1.648965789 0.553707034 2.97804739 0.00290091 0.071941195 
LINC00886 9.08877086 -2.146898592 0.707575206 -3.0341631 0.00241204 0.064811207 
IGKV1D-16 6.93627807 2.860665724 0.904019856 3.16438373 0.00155412 0.050407058 
RPL36A 11.5143082 -1.807908879 0.63218828 -2.8597634 0.00423957 0.089506041 
IGKV1-9 21.3184426 2.420315738 0.445460814 5.43328541 5.53E-08 1.30E-05 
IGKV1-12 28.8379236 1.873268342 0.519187155 3.60807914 0.00030847 0.017158351 
C4orf48 16.2266667 2.042514622 0.676239189 3.02040263 0.00252439 0.066556483 
IGKV1-5 114.356364 1.581175309 0.346292645 4.56600893 4.97E-06 0.000619277 
LINC02273 85.8005605 -2.869738289 0.353068293 -8.1279977 4.36E-16 3.87E-13 
CASC8 5.11174433 5.167273009 1.522268535 3.39445564 0.00068765 0.029616181 
MTND4P12 20.1409733 8.103583395 1.185717584 6.83432843 8.24E-12 4.60E-09 
CCDC153 24.420499 1.251605614 0.427010392 2.93108935 0.00337776 0.077616305 
LINC02432 50.6381145 1.269484538 0.283283996 4.481314 7.42E-06 0.000880522 
LINC01303 7.69174532 2.467868196 0.871381628 2.83213246 0.00462387 0.093809153 
LINC02384 80.3994719 -1.628229486 0.351129465 -4.6371201 3.53E-06 0.0004755 
IGKV1D-39 15.4616668 1.793593642 0.602288573 2.97796392 0.0029017 0.071941195 
AC040970.1 41.7916835 1.098313441 0.317469449 3.45958783 0.000541 0.025247915 
PKD1P5 30.1923736 3.000508907 0.575886722 5.21024152 1.89E-07 3.79E-05 
AC136475.5 17.136604 1.573731972 0.447124002 3.51967679 0.00043207 0.021855933 
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AC092746.1 18.7596704 1.925547281 0.480318799 4.00889427 6.10E-05 0.004917487 
LINC02446 52.9371732 -1.048838071 0.311587298 -3.366113 0.00076235 0.031398177 
A2MP1 11.5812199 -2.345776496 0.719732132 -3.2592355 0.00111713 0.040577357 
AC010175.1 7.31789622 -3.067824516 0.957251138 -3.2048272 0.00135144 0.04651037 
BTG1P1 13.2561584 -2.377595642 0.663458398 -3.5836394 0.00033884 0.018372919 
HP 34.7371255 1.994473371 0.387114032 5.15215985 2.58E-07 4.79E-05 
AC004241.1 8.09234656 1.684875222 0.576370917 2.92324816 0.003464 0.078876712 
PRKXP1 11.1844308 -5.536295706 1.421647403 -3.8942819 9.85E-05 0.007103538 
ITGB3 90.6314322 1.572650244 0.366140728 4.29520707 1.75E-05 0.001777615 
ZNF865 220.331423 1.016889535 0.293682723 3.46254464 0.00053509 0.025108135 
AC006504.1 15.5355161 -1.913169826 0.514546614 -3.7181662 0.00020067 0.012397391 
RHEX 9.60384261 1.77682153 0.590592586 3.00854019 0.00262506 0.067687486 
AGAP7P 54.9982537 1.013856649 0.288408895 3.51534459 0.00043918 0.021994204 
AL627309.6 128.650106 1.142151362 0.377287644 3.02726946 0.00246774 0.065722074 
AC027020.2 70.9074339 -2.302056883 0.275390257 -8.3592532 6.31E-17 6.34E-14 
NBPF8 143.147753 -1.801903301 0.282847279 -6.3705874 1.88E-10 8.11E-08 
AC136475.9 24.1233466 1.847819398 0.458423412 4.03081376 5.56E-05 0.00462914 
AC090948.1 23.3536127 -1.229977478 0.364300236 -3.3762742 0.00073475 0.03074525 
OR10AH1P 5.17696012 -5.049551503 1.555661173 -3.2459199 0.00117072 0.041719625 
FAM106A 6.90914206 -3.440058495 1.015255546 -3.3883671 0.0007031 0.030008196 
NBPF26 113.519596 -1.740081767 0.339704302 -5.1223425 3.02E-07 5.42E-05 
AC133644.2 4.9660609 -4.360938447 1.46661174 -2.9734785 0.00294445 0.072523934 
AC008033.3 29.1945259 -2.812090101 0.741951475 -3.7901267 0.00015057 0.009783186 
FP565260.1 41.7523197 -1.154557491 0.306434095 -3.7677188 0.00016475 0.010567589 
TRBV10-3 18.284526 -1.700103716 0.531463452 -3.1989099 0.00137948 0.047152654 
AC004556.3 6.17287836 6.546500927 1.552557654 4.21659119 2.48E-05 0.002381337 
AL136962.1 6.19139506 -2.538112996 0.865076426 -2.9339755 0.00334651 0.077139947 
HERC2P2 91.0626401 -1.331978762 0.300519765 -4.4322501 9.33E-06 0.001061159 
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TRBV12-4 17.9627112 1.352436454 0.453410083 2.98281071 0.00285615 0.071478982 
FP565260.3 11.3486246 5.854537604 1.487900121 3.93476519 8.33E-05 0.006308209 
TRBV7-9 24.4042987 -2.510449546 0.600076861 -4.1835467 2.87E-05 0.002687068 
IGLV2-8 24.6863656 1.417437062 0.489518037 2.89557678 0.00378462 0.083405594 
AC092135.3 15.4320987 1.518358099 0.495774252 3.06259975 0.00219423 0.062056048 
AC004241.5 7.55918351 2.407913382 0.684054621 3.52006011 0.00043145 0.021855933 
CCDC163 24.2988369 -2.616439795 0.416475858 -6.2823325 3.34E-10 1.32E-07 
LINC01163 9.30594238 -5.980437461 1.528947029 -3.9114746 9.17E-05 0.006811837 
LINC01127 98.7489988 1.584025415 0.253431296 6.25031495 4.10E-10 1.58E-07 
WASH5P 20.5866233 -1.750552293 0.573861195 -3.0504803 0.00228476 0.063436422 
IGHV5-10-1 12.1701267 -4.978437356 1.567227029 -3.1765898 0.00149018 0.049587024 
TRBJ1-6 4.84842286 -6.03598103 1.625166645 -3.714069 0.00020395 0.01249752 
TRBV7-2 15.5658433 -1.853192498 0.549286928 -3.373815 0.00074134 0.03074525 
AC008038.1 28.4620505 3.555411986 0.5595579 6.35396621 2.10E-10 8.79E-08 
AP000547.3 48.041844 1.254617289 0.407675148 3.0774927 0.0020875 0.060014602 
SCO2 8.3435759 2.282818201 0.722572943 3.15929101 0.00158153 0.050938192 
AC107959.4 6.52367446 2.309022878 0.806485936 2.86306651 0.00419562 0.089202889 
AC119673.3 15.504465 7.209960364 1.516052648 4.75574537 1.98E-06 0.000283844 
AC253572.2 4.82159664 -5.297967185 1.629880511 -3.2505249 0.00115192 0.041147083 
 
 
Table 2: Significantly upregulated genes after 24 hours of fluid restriction 
Gene Name baseMean log2FoldChange lfcSE stat p-value p- value (adjusted) 
AOC1 13.2594648 1.47405099 0.42898588 3.43612943 0.00059009 0.02695455 
TMEM176A 175.75525 1.52401939 0.31245416 4.87757749 1.07E-06 0.00016519 
CYP26B1 4.97314721 7.72458287 1.6057956 4.81043968 1.51E-06 0.00021828 
PGLYRP1 258.627824 1.66861291 0.27899473 5.98080437 2.22E-09 6.69E-07 
CD9 104.384725 1.38701 0.24917869 5.56632682 2.60E-08 6.33E-06 
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STAB1 708.338558 1.75297416 0.30629177 5.72321657 1.05E-08 2.81E-06 
TSPAN9 26.1037821 1.26781381 0.38117429 3.3260738 0.00088079 0.03439629 
SLC11A1 2712.29715 1.03625775 0.22968912 4.51156665 6.44E-06 0.00078227 
ADGRA2 28.2940504 1.09650506 0.38816836 2.82481823 0.00473074 0.09495505 
MYOM2 138.098539 3.25265497 0.418801 7.76658835 8.06E-15 6.75E-12 
TNFRSF9 61.2996965 1.02677921 0.29701459 3.45699923 0.00054623 0.02541302 
HOMER3 47.9458245 1.18350896 0.34346779 3.44576407 0.00056945 0.02628179 
ENTPD2 12.1369914 3.26379109 0.72878406 4.47840623 7.52E-06 0.00088349 
VASH1 131.434195 1.46695218 0.24564139 5.97192593 2.34E-09 6.93E-07 
FCGR2B 232.101751 1.32525201 0.17399204 7.61673932 2.60E-14 2.06E-11 
PANX2 222.719958 1.00472245 0.2573149 3.90464162 9.44E-05 0.00693883 
MGLL 97.4352203 1.51861447 0.25325195 5.99645708 2.02E-09 6.20E-07 
RAPGEF3 23.5667175 1.09135672 0.36598784 2.98194804 0.00286421 0.07147898 
COL5A3 66.7351813 1.52026625 0.28665512 5.30346795 1.14E-07 2.48E-05 
CTTN 30.9433437 1.26140761 0.37938872 3.32484216 0.00088469 0.03445932 
GNA11 31.0518915 1.0404154 0.33061392 3.14691957 0.00165 0.05160198 
SMOX 139.880631 1.44323594 0.42149612 3.42407878 0.00061689 0.02751172 
RPH3A 88.5143747 3.03467397 0.29748999 10.2009281 1.96E-24 5.92E-21 
PUS7 39.9430989 2.68494883 0.30451531 8.81712271 1.17E-18 1.77E-15 
DSP 18.4050665 7.41722239 1.49147201 4.97308856 6.59E-07 0.00010797 
TPTEP1 51.7839587 1.66412821 0.29693351 5.60438001 2.09E-08 5.34E-06 
BIK 11.0837612 2.29390429 0.66028013 3.47413801 0.0005125 0.02444742 
PVALB 4.28940047 2.61083241 0.8650437 3.01815089 0.00254322 0.06655648 
MMP9 728.808312 1.25737826 0.23969788 5.24567959 1.56E-07 3.26E-05 
CTSZ 2223.31135 1.30312056 0.21572364 6.04069423 1.53E-09 5.14E-07 
NTSR1 15.9192874 1.48570253 0.43823684 3.39018171 0.00069846 0.02991089 
MYL9 146.89307 2.68284514 0.66390872 4.04098497 5.32E-05 0.00455879 
BMX 30.5139435 1.12050441 0.34782209 3.22148724 0.00127527 0.04439594 
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PCYT1B 5.77712393 2.92847328 0.94605588 3.09545489 0.00196511 0.0579689 
NECAB2 62.2930721 1.521064 0.4314804 3.52522157 0.00042313 0.02176875 
RETN 52.8786028 1.71707899 0.42690275 4.0221783 5.77E-05 0.00472393 
TNNT1 19.3264322 2.19898613 0.58269271 3.77383498 0.00016076 0.01035578 
ADAP1 137.577509 1.00497236 0.33786371 2.97449038 0.00293476 0.07252217 
TMEM176B 414.672113 1.85337309 0.30733157 6.03053267 1.63E-09 5.36E-07 
CNTNAP3 52.4554446 1.32939128 0.43107605 3.08389037 0.00204313 0.05931256 
PRUNE2 15.3608566 1.52119869 0.49503505 3.07291111 0.00211982 0.06044128 
NPDC1 108.070995 1.10305707 0.33916971 3.25222755 0.00114504 0.04099853 
NEURL1 78.7058583 1.30012609 0.28401199 4.57771555 4.70E-06 0.00059546 
KRT23 182.373838 1.19190229 0.2349894 5.0721535 3.93E-07 6.98E-05 
RUNDC3A 199.196964 1.74585044 0.60436215 2.8887488 0.00386778 0.08409066 
P2RX1 532.646935 1.11460064 0.20639378 5.40035957 6.65E-08 1.52E-05 
VWF 31.9923714 1.70933105 0.41937354 4.07591539 4.58E-05 0.00401684 
VNN1 115.504766 1.14081615 0.28699667 3.97501528 7.04E-05 0.00549652 
PDGFRB 33.6187278 1.34246858 0.39711663 3.38053979 0.00072344 0.03037625 
TP53I3 34.0432776 1.11630849 0.33893995 3.2935288 0.00098938 0.03745458 
PADI2 1378.36863 1.84555548 0.18890732 9.7696344 1.52E-22 3.82E-19 
PILRB 110.243916 1.71955168 0.28537752 6.02553311 1.69E-09 5.41E-07 
RASL11A 23.6922764 1.12752416 0.39397209 2.86193915 0.00421058 0.08939471 
PHF24 12.9201279 2.30130835 0.56287645 4.08847866 4.34E-05 0.00382766 
SARDH 36.6080126 1.16244615 0.38118281 3.04957651 0.00229164 0.06343642 
ENKD1 47.5916999 1.07955457 0.3118372 3.46191726 0.00053634 0.02510813 
PI3 656.51376 2.85282332 0.38647731 7.3816063 1.56E-13 1.07E-10 
DOK4 32.1392494 1.09893511 0.32040699 3.42981003 0.000604 0.02734161 
SRD5A3 27.5975792 1.04348514 0.3655881 2.85426448 0.00431366 0.09043688 
GNAZ 46.1131603 1.40270487 0.4092458 3.42753641 0.00060908 0.02740699 
LRRC6 39.743579 2.44959754 0.39486715 6.2035992 5.52E-10 2.03E-07 
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CDKN1C 35.7565519 1.74628464 0.4445349 3.92834091 8.55E-05 0.00638286 
GADD45G 8.46259282 2.28509244 0.6519975 3.50475645 0.00045703 0.02258753 
IQCN 115.846263 1.04740936 0.24089749 4.34794628 1.37E-05 0.00144856 
LRP3 60.0865504 1.26872674 0.36534284 3.47270181 0.00051525 0.02450107 
NAPSB 619.180656 1.96260723 0.29090754 6.74649825 1.51E-11 7.87E-09 
RAMP1 8.24784177 2.80867617 0.88275389 3.18172051 0.00146403 0.04893302 
JCHAIN 190.149036 2.06930513 0.43805176 4.72388264 2.31E-06 0.00032295 
IGHMBP2 213.722182 1.02781952 0.19167529 5.36229531 8.22E-08 1.82E-05 
CHIT1 22.9565618 1.55188269 0.4605104 3.3699189 0.0007519 0.03105257 
TMTC1 22.4485241 1.14438401 0.36736048 3.11515275 0.0018385 0.05553808 
CTIF 14.0755194 1.43125298 0.50913533 2.81114451 0.00493656 0.09740015 
GSTM1 49.1359819 1.01925119 0.33892112 3.00734047 0.00263544 0.06779298 
SPOCD1 21.489969 1.8009114 0.60167822 2.99314708 0.00276117 0.06983528 
BLK 94.8777949 1.20587103 0.29218117 4.1271347 3.67E-05 0.00329574 
DAB2IP 6.57825246 2.16479477 0.695968 3.11048032 0.00186783 0.05586453 
TUBB2A 81.3852019 4.60481489 0.53223221 8.65189068 5.07E-18 6.36E-15 
B4GALNT3 63.1635801 1.48769912 0.34697517 4.28762412 1.81E-05 0.00181485 
HDC 99.9418564 1.26536096 0.32965377 3.83845435 0.00012381 0.00847878 
KIFC3 56.2448831 1.23370115 0.3121931 3.95172455 7.76E-05 0.00602882 
IFITM3 1478.86024 1.54634124 0.3172468 4.8742533 1.09E-06 0.0001663 
ZNF787 174.966842 1.0061474 0.30678039 3.27969922 0.00103918 0.03858269 
FCRL5 208.281554 1.81948983 0.2127273 8.55315639 1.20E-17 1.39E-14 
AQP10 17.0027138 2.53426767 0.66574477 3.80666554 0.00014085 0.00927486 
THNSL2 24.0088464 2.44130034 0.46949315 5.19986363 1.99E-07 3.96E-05 
CHST7 75.1321163 1.2047339 0.28778372 4.1862476 2.84E-05 0.0026719 
GRIK4 16.1513864 2.52810651 0.52388912 4.82565182 1.40E-06 0.00020623 
ESAM 54.3572373 1.70868508 0.38582401 4.42866442 9.48E-06 0.00106664 
ALDOA 84.312674 1.61901462 0.42189616 3.83747181 0.00012431 0.00847878 
 42 
PRSS23 98.9152175 1.15172032 0.32217362 3.57484371 0.00035044 0.01886604 
CLEC4F 17.6097593 4.47402739 0.6253568 7.15435957 8.41E-13 5.28E-10 
PGM5 28.8185383 2.32478929 0.4962408 4.68480083 2.80E-06 0.00038754 
CFAP161 5.91880441 2.15760353 0.75176355 2.87005606 0.00410399 0.08769925 
CPA5 9.95164981 2.28261837 0.67993826 3.3570965 0.00078766 0.03203398 
CDA 737.062091 1.17140909 0.29013287 4.0374918 5.40E-05 0.00460104 
SPON2 734.976749 1.11587684 0.31831919 3.50552807 0.0004557 0.02258753 
TPPP3 69.8729606 1.26644442 0.37534184 3.37410932 0.00074055 0.03074525 
CPAMD8 64.1278729 1.00386367 0.2966699 3.38377328 0.00071497 0.03035904 
GATD3A 19.37976 2.39337698 0.47653045 5.02250581 5.10E-07 8.84E-05 
SHKBP1 2416.44899 1.043306 0.24368243 4.28141666 1.86E-05 0.00185388 
LMNA 118.017928 1.32846585 0.32093059 4.13941795 3.48E-05 0.00314287 
PPP1R35 57.550073 1.06230903 0.37469842 2.83510413 0.00458108 0.09341411 
SH2B2 171.490359 1.23005858 0.29459501 4.17542235 2.97E-05 0.00275062 
TREML1 124.935517 1.14493568 0.33527324 3.4149331 0.00063798 0.02831813 
SLC1A7 28.7840034 1.68775574 0.47922553 3.52184024 0.00042856 0.02185593 
KIAA1522 19.8462419 1.54523296 0.41602391 3.71428886 0.00020378 0.01249752 
ALPL 1866.77209 1.21270988 0.24569934 4.93574733 7.98E-07 0.00012804 
HAAO 48.4168066 1.01345922 0.34574994 2.93119131 0.00337665 0.0776163 
CXCL5 8.14767985 2.07160075 0.70245223 2.94909841 0.00318702 0.07574885 
PPBP 157.414238 1.34956501 0.38594409 3.49678892 0.00047089 0.0230463 
PF4 273.057628 1.43193829 0.32804342 4.36508763 1.27E-05 0.00137804 
ERAP2 474.581193 1.34836273 0.2134353 6.31743089 2.66E-10 1.08E-07 
SHROOM1 33.336861 1.14534125 0.40415983 2.83388198 0.00459863 0.09354894 
METTL27 4.63585109 2.49430352 0.86948232 2.86872254 0.00412133 0.08787122 
TMEM63C 40.0281866 1.57431209 0.36477318 4.31586573 1.59E-05 0.00165272 
ZNF503 6.3979253 2.16721399 0.76507997 2.83266336 0.0046162 0.09377973 
ARHGEF40 626.058021 1.41904006 0.19858047 7.14591943 8.94E-13 5.39E-10 
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UBTD1 84.1217302 1.08125874 0.30976353 3.49059403 0.00048195 0.02343511 
CKB 28.8721275 1.52266532 0.43022498 3.53923036 0.0004013 0.02073892 
PLD4 215.672964 1.0187692 0.30992327 3.28716593 0.00101201 0.03813767 
MS4A14 125.068658 1.12437296 0.22511984 4.99455288 5.90E-07 0.00010102 
CA4 99.0674267 1.1961363 0.30687151 3.89784087 9.71E-05 0.00703363 
TMC4 7.18569199 2.88043667 1.0081763 2.85707635 0.00427563 0.09001514 
PPP1R14A 11.8807694 1.95876886 0.67758254 2.89081957 0.00384239 0.08399726 
RILP 87.9765607 1.16259514 0.39458675 2.94636134 0.00321537 0.07574885 
TRPV3 7.44854795 2.31307759 0.78353369 2.95210993 0.00315611 0.07574885 
KRT1 135.613373 1.54705969 0.39978673 3.86971247 0.00010896 0.00760426 
EVPL 11.4367104 1.92819397 0.54398175 3.54459314 0.00039322 0.02043928 
FTH1 986.15826 1.53207533 0.41926268 3.65421347 0.00025797 0.01517485 
NT5DC2 50.3960517 1.18531852 0.33134597 3.57728361 0.00034718 0.01875786 
RNASE2 171.688383 1.30188579 0.4041098 3.22161398 0.00127471 0.04439594 
PCBP1 79.9687816 1.261489 0.40949424 3.08060253 0.00206582 0.0595415 
GP9 74.6960209 1.82634724 0.54419706 3.35604024 0.00079067 0.03203916 
MYO7B 101.571437 1.63528522 0.2654015 6.16155235 7.20E-10 2.53E-07 
MZB1 174.328519 1.08945807 0.36791403 2.96117562 0.00306467 0.07463143 
KRT72 119.067756 1.69766948 0.25991096 6.53173481 6.50E-11 3.06E-08 
PTCRA 42.1008146 1.63521017 0.53813577 3.03865726 0.00237635 0.06442645 
KNDC1 23.7027295 1.73850616 0.41588241 4.18028297 2.91E-05 0.0027091 
PWWP2B 155.844808 1.00281097 0.2970827 3.37552801 0.00073674 0.03074525 
CYP4F22 19.2658839 1.57465065 0.49900656 3.15557106 0.00160184 0.05094129 
ABLIM3 39.7652498 1.56736839 0.45644837 3.43383503 0.00059511 0.02710161 
C1QA 27.097909 1.5034581 0.45387203 3.31251542 0.00092461 0.03546457 
CCR9 20.0117734 1.19617156 0.40880993 2.92598461 0.00343368 0.07854216 
LRFN4 21.746719 1.45378593 0.47692107 3.04827366 0.0023016 0.06354277 
PHOSPHO1 1934.01789 1.17759918 0.32491897 3.62428577 0.00028976 0.01651537 
 44 
PELI3 63.4751197 1.00876014 0.27778088 3.63149595 0.00028178 0.01615056 
RIN1 61.5251388 1.0340588 0.30301975 3.41251283 0.00064367 0.02839315 
CHST2 247.804704 1.15589991 0.21512875 5.37306095 7.74E-08 1.74E-05 
TP53I11 563.601709 1.12428712 0.18956337 5.93093008 3.01E-09 8.73E-07 
SPHK1 39.9278962 1.06752582 0.3622024 2.9473185 0.00320543 0.07574885 
BOK 36.0160986 1.32283193 0.42460364 3.11545121 0.00183664 0.05553808 
BASP1 1473.74636 1.19592035 0.24753538 4.83131076 1.36E-06 0.00020244 
CRACR2B 22.4982219 1.5496958 0.553093 2.80187199 0.0050807 0.09920533 
CD151 212.881919 1.99459604 0.32030103 6.22725462 4.75E-10 1.79E-07 
ODF3B 186.504204 1.12403945 0.38093952 2.95070318 0.00317051 0.07574885 
LRRC75B 10.678909 1.60897109 0.56526019 2.84642562 0.00442131 0.09159061 
LYNX1 33.1633398 1.03420996 0.3512611 2.94427693 0.0032371 0.07600635 
FZD2 41.814348 1.16387096 0.34144105 3.40870247 0.00065273 0.02860231 
CUEDC1 251.577836 1.1114469 0.21433328 5.18560107 2.15E-07 4.22E-05 
CRIP2 65.0132741 1.18950718 0.34046615 3.4937605 0.00047627 0.02323387 
SPNS2 23.4448991 1.3715431 0.43240831 3.17187037 0.00151461 0.04984972 
AFMID 35.4656138 1.00067037 0.32576086 3.07179441 0.00212776 0.06051677 
BEGAIN 21.298677 1.8211087 0.3681015 4.94730041 7.52E-07 0.00012197 
PCBP3 22.591583 1.16870931 0.41463958 2.81861494 0.00482313 0.09616921 
ASCL2 56.628866 1.38359386 0.42773664 3.23468635 0.00121776 0.04301549 
KREMEN1 230.06802 1.20861302 0.24261634 4.98158131 6.31E-07 0.00010447 
FAM3B 5.05724662 4.65529471 1.19805138 3.88572208 0.00010203 0.00728883 
CLDN5 16.6471787 1.76807986 0.54354595 3.25286183 0.00114249 0.04099853 
TACSTD2 10.2590396 2.76311541 0.65790848 4.19984769 2.67E-05 0.00253219 
IL3RA 173.939752 2.23366992 0.2665364 8.38035597 5.28E-17 5.68E-14 
RGPD2 6.89333993 3.23049333 0.78973889 4.09058409 4.30E-05 0.00381539 
GAS2L1 93.9893737 1.70687926 0.35440661 4.81616086 1.46E-06 0.00021418 
KRT73 28.6165619 1.16833276 0.36802454 3.17460557 0.0015004 0.04959885 
 45 
MARC1 119.703506 1.13807867 0.23191046 4.90740555 9.23E-07 0.00014345 
CEACAM19 22.8362654 1.26119359 0.42477469 2.96908838 0.00298685 0.07320931 
TNFRSF18 34.1996245 1.88766783 0.48517177 3.89072068 9.99E-05 0.00717429 
LILRA5 295.138392 1.12757133 0.27710323 4.06913823 4.72E-05 0.00411157 
PEAR1 22.3064995 1.33345034 0.39077827 3.41229401 0.00064419 0.02839315 
KAZN 45.7917811 1.07511949 0.31392127 3.42480613 0.00061524 0.02751172 
C20orf204 9.15579314 1.89658895 0.59914956 3.1654683 0.00154834 0.05040706 
SLC25A29 245.394126 1.26988314 0.20572221 6.17280541 6.71E-10 2.41E-07 
LYPD2 23.2244885 3.12675138 0.66810751 4.68001232 2.87E-06 0.0003931 
MMP17 100.6464 1.18522212 0.30529001 3.88228275 0.00010348 0.00732331 
COLGALT2 15.3550219 2.95447844 0.670644 4.40543486 1.06E-05 0.0011616 
SHISA4 54.6549231 1.74152464 0.51406718 3.38773747 0.00070472 0.0300082 
GGTA1P 28.3599803 2.0828161 0.54693512 3.80815935 0.00014001 0.00927486 
TAP2 4.29238861 6.63718192 1.68580784 3.9370928 8.25E-05 0.00627891 
HLA-C 2563.64945 5.43357961 0.19827662 27.4040365 2.45E-165 3.70E-161 
LILRB3 612.767142 1.06702338 0.17794156 5.99648196 2.02E-09 6.20E-07 
FAM153CP 11.4799709 2.30555915 0.52944166 4.35469915 1.33E-05 0.00141451 
MROH6 19.517688 1.35603364 0.45708474 2.96670078 0.00301014 0.07354103 
CD177 26.4100031 1.90671178 0.5836872 3.26666709 0.00108822 0.03981496 
FAM71F2 21.8591988 1.33755113 0.42913898 3.11682506 0.0018281 0.05544624 
HBM 380.084321 2.19385222 0.72136192 3.04126425 0.00235587 0.06421769 
HLA-H 6.18873189 5.59181182 1.54585622 3.61729102 0.0002977 0.01680737 
IGKC 3130.71934 1.51266163 0.31206727 4.84722929 1.25E-06 0.00018872 
IGKV4-1 195.18647 1.26912102 0.29583349 4.28998427 1.79E-05 0.00180772 
IGLV4-69 29.2735012 1.71624194 0.46852872 3.66304535 0.00024923 0.01484964 
IGLV8-61 28.1624064 1.61833526 0.42514142 3.80658102 0.0001409 0.00927486 
IGLV1-47 38.9438056 1.44883402 0.38121249 3.80059433 0.00014435 0.00941958 
IGLV7-46 21.1370091 2.13756667 0.5867871 3.64283175 0.00026966 0.01563377 
 46 
IGLV7-43 7.57021029 2.28171461 0.78349074 2.91224195 0.00358845 0.0801151 
IGLV2-23 76.4799088 2.44098344 0.35380675 6.89919968 5.23E-12 3.03E-09 
IGLV2-14 93.0209661 2.02962214 0.27352067 7.42036116 1.17E-13 8.38E-11 
IGLV3-12 14.0443417 4.26229819 0.77006409 5.53499151 3.11E-08 7.45E-06 
IGLV2-11 57.2827447 1.71865628 0.33283276 5.16372332 2.42E-07 4.56E-05 
IGLC2 496.144016 1.36136316 0.3657843 3.72176483 0.00019784 0.01233695 
IGLC3 276.846258 1.70591751 0.39111192 4.3617119 1.29E-05 0.00137963 
TRBV20-1 29.9890143 1.82766828 0.39538638 4.62248675 3.79E-06 0.00050137 
IGHA2 87.7692689 2.42917713 0.52618209 4.61660934 3.90E-06 0.00051128 
IGHG4 42.1442957 3.03660218 0.67071897 4.52738379 5.97E-06 0.00073187 
IGHG2 227.698736 1.62689783 0.36569603 4.44877083 8.64E-06 0.00099377 
IGHA1 643.706474 2.2362286 0.36897743 6.06061085 1.36E-09 4.65E-07 
IGHG1 681.98212 1.88385034 0.36372731 5.17929314 2.23E-07 4.30E-05 
IGHV3-33 25.0740727 1.56758568 0.46362238 3.38116911 0.00072178 0.03037625 
IGHV4-39 27.8675925 3.2342556 0.47590631 6.79599228 1.08E-11 5.79E-09 
STARD10 169.244722 1.29378517 0.32370831 3.99676228 6.42E-05 0.00511689 
MEG3 28.056331 4.43213957 0.50639414 8.7523517 2.09E-18 2.86E-15 
RPL13P12 204.154958 2.68023801 0.57437965 4.66631782 3.07E-06 0.00041643 
MYL5 66.8614947 1.00784575 0.30067804 3.3519101 0.00080256 0.03234706 
C6orf226 30.8680774 1.36321876 0.48524097 2.80936453 0.00496394 0.09781234 
CEBPD 596.102999 1.18450185 0.25816502 4.58815772 4.47E-06 0.00057125 
FXYD7 13.9430715 1.74834298 0.57789853 3.02534594 0.00248349 0.06579282 
HBD 169.656105 1.48953826 0.38785355 3.8404657 0.0001228 0.00845253 
LINC00937 52.6287927 1.43239423 0.36717252 3.90114769 9.57E-05 0.00697174 
NBPF13P 5.84834473 7.29741211 1.66289511 4.38837789 1.14E-05 0.00124742 
AC138969.3 7.19674786 3.59682226 1.18348044 3.03919029 0.00237215 0.06442645 
CYP4F29P 67.0239467 4.74667657 0.5317413 8.92666523 4.39E-19 8.27E-16 
ORM1 59.5753637 1.77510339 0.4440285 3.99772404 6.40E-05 0.00511689 
 47 
NAMPTP1 134.880833 6.12966652 0.5577002 10.9909705 4.22E-28 2.12E-24 
LINC01001 42.4325132 1.38191748 0.43263116 3.19421622 0.00140211 0.04765829 
AC005392.2 42.344355 8.46401798 1.47597392 5.73453086 9.78E-09 2.68E-06 
AC104809.2 60.7747713 1.39744474 0.37826198 3.69438328 0.00022042 0.01334389 
EIF3FP3 64.6606268 1.30737082 0.32407866 4.03411574 5.48E-05 0.00462914 
DDX11L10 36.2646643 2.01140244 0.43766598 4.59574774 4.31E-06 0.00055555 
SMIM1 60.4431567 3.02091707 0.75603669 3.99572812 6.45E-05 0.00511689 
AP001189.1 65.2596979 3.19133423 0.47345986 6.74045363 1.58E-11 7.93E-09 
MAP3K2-
DT 
16.6695106 2.10628866 0.46096954 4.5692578 4.89E-06 0.00061484 
DEFA3 319.872874 1.32793893 0.32925528 4.03315911 5.50E-05 0.00462914 
IGKV1-17 17.1410283 1.89042636 0.52291437 3.61517385 0.00030015 0.01682084 
IGKV1-16 31.5108611 1.64896579 0.55370703 2.97804739 0.00290091 0.07194119 
IGKV1D-16 6.93627807 2.86066572 0.90401986 3.16438373 0.00155412 0.05040706 
IGKV1-9 21.3184426 2.42031574 0.44546081 5.43328541 5.53E-08 1.30E-05 
IGKV1-12 28.8379236 1.87326834 0.51918715 3.60807914 0.00030847 0.01715835 
C4orf48 16.2266667 2.04251462 0.67623919 3.02040263 0.00252439 0.06655648 
IGKV1-5 114.356364 1.58117531 0.34629264 4.56600893 4.97E-06 0.00061928 
CASC8 5.11174433 5.16727301 1.52226854 3.39445564 0.00068765 0.02961618 
MTND4P12 20.1409733 8.10358339 1.18571758 6.83432843 8.24E-12 4.60E-09 
CCDC153 24.420499 1.25160561 0.42701039 2.93108935 0.00337776 0.0776163 
LINC02432 50.6381145 1.26948454 0.283284 4.481314 7.42E-06 0.00088052 
LINC01303 7.69174532 2.4678682 0.87138163 2.83213246 0.00462387 0.09380915 
IGKV1D-39 15.4616668 1.79359364 0.60228857 2.97796392 0.0029017 0.07194119 
AC040970.1 41.7916835 1.09831344 0.31746945 3.45958783 0.000541 0.02524791 
PKD1P5 30.1923736 3.00050891 0.57588672 5.21024152 1.89E-07 3.79E-05 
AC136475.5 17.136604 1.57373197 0.447124 3.51967679 0.00043207 0.02185593 
AC092746.1 18.7596704 1.92554728 0.4803188 4.00889427 6.10E-05 0.00491749 
 48 
HP 34.7371255 1.99447337 0.38711403 5.15215985 2.58E-07 4.79E-05 
AC004241.1 8.09234656 1.68487522 0.57637092 2.92324816 0.003464 0.07887671 
ITGB3 90.6314322 1.57265024 0.36614073 4.29520707 1.75E-05 0.00177762 
ZNF865 220.331423 1.01688954 0.29368272 3.46254464 0.00053509 0.02510813 
RHEX 9.60384261 1.77682153 0.59059259 3.00854019 0.00262506 0.06768749 
AGAP7P 54.9982537 1.01385665 0.2884089 3.51534459 0.00043918 0.0219942 
AL627309.6 128.650106 1.14215136 0.37728764 3.02726946 0.00246774 0.06572207 
AC136475.9 24.1233466 1.8478194 0.45842341 4.03081376 5.56E-05 0.00462914 
AC004556.3 6.17287836 6.54650093 1.55255765 4.21659119 2.48E-05 0.00238134 
TRBV12-4 17.9627112 1.35243645 0.45341008 2.98281071 0.00285615 0.07147898 
FP565260.3 11.3486246 5.8545376 1.48790012 3.93476519 8.33E-05 0.00630821 
IGLV2-8 24.6863656 1.41743706 0.48951804 2.89557678 0.00378462 0.08340559 
AC092135.3 15.4320987 1.5183581 0.49577425 3.06259975 0.00219423 0.06205605 
AC004241.5 7.55918351 2.40791338 0.68405462 3.52006011 0.00043145 0.02185593 
LINC01127 98.7489988 1.58402542 0.2534313 6.25031495 4.10E-10 1.58E-07 
AC008038.1 28.4620505 3.55541199 0.5595579 6.35396621 2.10E-10 8.79E-08 
AP000547.3 48.041844 1.25461729 0.40767515 3.0774927 0.0020875 0.0600146 
SCO2 8.3435759 2.2828182 0.72257294 3.15929101 0.00158153 0.05093819 
AC107959.4 6.52367446 2.30902288 0.80648594 2.86306651 0.00419562 0.08920289 





Table 3: Significantly downregulated genes following the 24 hour fluid restriction 
Gene Name baseMean log2FoldChange lfcSE stat p-value p- value (adjusted) 
SH3YL1 148.208022 -1.2499302 0.18759997 -6.6627419 2.69E-11 1.31E-08 
RAP1GAP 10.5134469 -1.9914954 0.63744349 -3.1241912 0.00178295 0.0544051 
 49 
DDX43 8.05222558 -2.02006 0.71161103 -2.8387138 0.00452958 0.09268299 
NRCAM 20.8508692 -1.9375611 0.49939616 -3.8798077 0.00010454 0.00734839 
ITGA6 277.157866 -1.0363835 0.25248346 -4.1047581 4.05E-05 0.00361007 
GZMH 553.486952 -1.0263243 0.32834105 -3.1257873 0.0017733 0.05422047 
FOLR3 249.093949 -2.7353067 0.30619774 -8.933138 4.14E-19 8.27E-16 
CEP70 10.16909 -2.0038972 0.65977893 -3.0372253 0.00238767 0.06457794 
HSPE1 11.1859989 -1.9579321 0.67124371 -2.9168721 0.00353561 0.07978404 
PLCL1 31.0975482 -1.0408305 0.33573497 -3.1001551 0.00193419 0.05750696 
PZP 14.2720663 -1.9115238 0.60564305 -3.1561888 0.00159845 0.05094099 
ENOSF1 143.181808 -1.0181224 0.27341499 -3.7237255 0.0001963 0.01232955 
RSAD2 112.233194 -1.2145743 0.23162049 -5.2438122 1.57E-07 3.26E-05 
BORA 24.0436989 -1.1960678 0.42249261 -2.8309792 0.00464057 0.0938953 
MYCBPAP 6.22424239 -4.1473839 1.16891993 -3.5480479 0.0003881 0.02031314 
ERMN 54.4527233 -1.0646897 0.34498914 -3.0861543 0.00202764 0.05911911 
IFI44 102.833594 -1.1266251 0.31323264 -3.5967679 0.0003222 0.01777793 
KIF21A 35.9566422 -1.0873974 0.36451825 -2.9831083 0.00285337 0.07147898 
ZNF614 52.897518 -1.0328722 0.31487368 -3.2802748 0.00103706 0.03858269 
GDF7 20.1793779 -1.4356878 0.49194777 -2.9183744 0.00351862 0.07963321 
ETAA1 33.8854162 -1.4311718 0.41960617 -3.4107502 0.00064784 0.02847114 
USP53 67.570782 -1.0720693 0.35816694 -2.9932111 0.00276059 0.06983528 
TMEM209 47.9758831 -1.053522 0.35757554 -2.9462921 0.00321609 0.07574885 
PLCH2 54.0343188 -1.610574 0.40882754 -3.9394949 8.17E-05 0.00625597 
TAGLN 260.037973 -1.1556006 0.20744222 -5.5707105 2.54E-08 6.33E-06 
SPEF2 30.8363048 -1.1051585 0.3799914 -2.9083776 0.00363309 0.08065574 
GPR15 24.4335167 -1.2855537 0.42238762 -3.0435401 0.00233812 0.06408157 
HTR6 9.32266657 -4.3578829 0.94033065 -4.6344154 3.58E-06 0.0004775 
NAE1 80.3460695 -1.300588 0.4160273 -3.1262083 0.00177076 0.05422047 
ICOSLG 10.8277074 -2.8735597 0.74671727 -3.8482566 0.00011896 0.0082258 
 50 
S100B 60.6625586 -2.9314899 0.55754099 -5.2578913 1.46E-07 3.14E-05 
PTPN13 24.9313333 -1.5505526 0.44451653 -3.4881776 0.00048632 0.02349635 
CXCL1 31.5863319 -1.1183575 0.36218683 -3.0877918 0.0020165 0.05901385 
KIAA1324L 30.2294694 -1.5648217 0.41143116 -3.8033621 0.00014275 0.00935541 
SLC13A4 30.9757276 -1.1587662 0.35387961 -3.2744644 0.00105862 0.03901641 
ARHGAP12 71.4988372 -1.0162762 0.31572321 -3.2188835 0.00128691 0.04464718 
LRR1 24.553472 -1.3935341 0.45811449 -3.0418904 0.00235097 0.06421769 
NKX3-1 51.2661846 -1.9883261 0.38456939 -5.1702661 2.34E-07 4.46E-05 
THEMIS 39.0882417 -1.4331676 0.3387176 -4.2311578 2.32E-05 0.00226102 
LRRN3 97.2226026 -1.1207436 0.35502275 -3.1568221 0.00159499 0.05093819 
AL162457.1 11.2659723 -2.0143057 0.70422146 -2.8603299 0.004232 0.08950448 
HLA-DQB1 650.866394 -8.7190556 1.04833828 -8.3170249 9.02E-17 8.50E-14 
PLCXD1 172.013151 -1.0511272 0.18882506 -5.5666722 2.60E-08 6.33E-06 
PNMA3 98.2252686 -2.610849 0.29451211 -8.8649971 7.65E-19 1.28E-15 
ADARB2 16.0694759 -7.8185049 1.49221286 -5.2395372 1.61E-07 3.28E-05 
IFIT1 181.399007 -1.2206525 0.24860679 -4.9099725 9.11E-07 0.00014345 
MST1L 4.31670565 -3.2086222 1.05947655 -3.0284976 0.00245773 0.06568763 
RHD 44.6483113 -1.0150558 0.31362761 -3.2365002 0.00121005 0.04291839 
ANKRD34B 8.91390722 -2.7705473 0.93218585 -2.9720975 0.00295773 0.0727321 
DRICH1 5.81115732 -2.6764096 0.85182788 -3.1419606 0.00167821 0.05216911 
HLA-DRB1 806.205067 -2.0655936 0.35936333 -5.7479256 9.03E-09 2.57E-06 
PRTN3 15.7653874 -2.9146841 0.95743397 -3.0442665 0.00233248 0.06408157 
HLA-DQA1 650.529431 -5.8295408 0.34172405 -17.059206 2.99E-65 2.25E-61 
KIAA1671 42.6201257 -1.0587327 0.31535865 -3.3572337 0.00078727 0.03203398 
HLA-DRB5 303.436724 -5.1161322 0.79454895 -6.4390397 1.20E-10 5.49E-08 
AGPAT1 12.3554138 -6.7326667 1.51931258 -4.4313901 9.36E-06 0.00106116 
LINC01291 47.9605655 -8.3907689 1.46969815 -5.7091784 1.14E-08 3.00E-06 
HCP5 49.5219513 -5.8151656 0.79462524 -7.3181234 2.51E-13 1.65E-10 
 51 
TRGC1 137.722371 -1.0357439 0.23740057 -4.3628536 1.28E-05 0.00137963 
TRGV9 53.4065378 -2.2381147 0.39026943 -5.7347936 9.76E-09 2.68E-06 
TRBV28 16.4397119 -2.1088933 0.52117512 -4.0464197 5.20E-05 0.00447973 
TRAV8-3 29.2365694 -1.1050953 0.33350009 -3.3136281 0.00092094 0.03541386 
TRDV2 85.5566333 -2.3989094 0.37562049 -6.3865243 1.70E-10 7.52E-08 
GOLGA8B 200.669385 -1.4383283 0.30380861 -4.7343237 2.20E-06 0.00030963 
BCORP1 58.7522012 -1.7378829 0.33146939 -5.2429663 1.58E-07 3.26E-05 
AC005082.1 6.44256664 -3.6044603 1.01050677 -3.5669828 0.00036112 0.01937171 
TRGC2 190.860015 -1.3198772 0.25729523 -5.129816 2.90E-07 5.27E-05 
RPL10P6 47.9001424 -6.7268118 0.89360842 -7.5276952 5.16E-14 3.89E-11 
RPL10P9 218.429683 -4.3885169 0.41122151 -10.671905 1.38E-26 5.19E-23 
CCT6P3 36.8809231 -1.0523272 0.3451014 -3.0493277 0.00229354 0.06343642 
LINC00649 202.293852 -1.1186966 0.24909161 -4.4911054 7.09E-06 0.00084767 
LINC00886 9.08877086 -2.1468986 0.70757521 -3.0341631 0.00241204 0.06481121 
RPL36A 11.5143082 -1.8079089 0.63218828 -2.8597634 0.00423957 0.08950604 
LINC02273 85.8005605 -2.8697383 0.35306829 -8.1279977 4.36E-16 3.87E-13 
LINC02384 80.3994719 -1.6282295 0.35112946 -4.6371201 3.53E-06 0.0004755 
LINC02446 52.9371732 -1.0488381 0.3115873 -3.366113 0.00076235 0.03139818 
A2MP1 11.5812199 -2.3457765 0.71973213 -3.2592355 0.00111713 0.04057736 
AC010175.1 7.31789622 -3.0678245 0.95725114 -3.2048272 0.00135144 0.04651037 
BTG1P1 13.2561584 -2.3775956 0.6634584 -3.5836394 0.00033884 0.01837292 
PRKXP1 11.1844308 -5.5362957 1.4216474 -3.8942819 9.85E-05 0.00710354 
AC006504.1 15.5355161 -1.9131698 0.51454661 -3.7181662 0.00020067 0.01239739 
AC027020.2 70.9074339 -2.3020569 0.27539026 -8.3592532 6.31E-17 6.34E-14 
NBPF8 143.147753 -1.8019033 0.28284728 -6.3705874 1.88E-10 8.11E-08 
AC090948.1 23.3536127 -1.2299775 0.36430024 -3.3762742 0.00073475 0.03074525 
OR10AH1P 5.17696012 -5.0495515 1.55566117 -3.2459199 0.00117072 0.04171963 
FAM106A 6.90914206 -3.4400585 1.01525555 -3.3883671 0.0007031 0.0300082 
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NBPF26 113.519596 -1.7400818 0.3397043 -5.1223425 3.02E-07 5.42E-05 
AC133644.2 4.9660609 -4.3609384 1.46661174 -2.9734785 0.00294445 0.07252393 
AC008033.3 29.1945259 -2.8120901 0.74195147 -3.7901267 0.00015057 0.00978319 
FP565260.1 41.7523197 -1.1545575 0.3064341 -3.7677188 0.00016475 0.01056759 
TRBV10-3 18.284526 -1.7001037 0.53146345 -3.1989099 0.00137948 0.04715265 
AL136962.1 6.19139506 -2.538113 0.86507643 -2.9339755 0.00334651 0.07713995 
HERC2P2 91.0626401 -1.3319788 0.30051977 -4.4322501 9.33E-06 0.00106116 
TRBV7-9 24.4042987 -2.5104495 0.60007686 -4.1835467 2.87E-05 0.00268707 
CCDC163 24.2988369 -2.6164398 0.41647586 -6.2823325 3.34E-10 1.32E-07 
LINC01163 9.30594238 -5.9804375 1.52894703 -3.9114746 9.17E-05 0.00681184 
WASH5P 20.5866233 -1.7505523 0.57386119 -3.0504803 0.00228476 0.06343642 
IGHV5-10-1 12.1701267 -4.9784374 1.56722703 -3.1765898 0.00149018 0.04958702 
TRBJ1-6 4.84842286 -6.035981 1.62516665 -3.714069 0.00020395 0.01249752 
TRBV7-2 15.5658433 -1.8531925 0.54928693 -3.373815 0.00074134 0.03074525 




Appendix B: Upregulated Biological Process, Molecular Function, and Cellular Component GO Term analysis  
 
Table 4: DAVID analysis of biological process GO terms 
Term Biological Process Count % PValue Fold 
Enrichment 
Benjamini FDR 
GO:0030168 platelet activation 9 409% 3E-05 7.467 0.025 0.043 
GO:0006954 inflammatory response 14 636% 2E-04 3.524 0.078 0.273 
GO:0006955 immune response 14 636% 5E-04 3.173 0.138 0.748 
GO:0002576 platelet degranulation 7 318% 7E-04 6.484 0.155 1.135 
GO:0016525 negative regulation of angiogenesis 5 227% 4E-03 7.694 0.522 6.038 
GO:0045087 innate immune response 12 545% 6E-03 2.663 0.573 8.274 
 53 
GO:0032496 response to lipopolysaccharide 7 318% 7E-03 4.072 0.630 11.080 
GO:0006937 regulation of muscle contraction 3 136% 9E-03 20.445 0.651 13.259 
GO:0007596 blood coagulation 7 318% 1E-02 3.630 0.733 18.186 
GO:0002690 positive regulation of leukocyte chemotaxis 3 136% 1E-02 15.902 0.749 20.817 
GO:0007166 cell surface receptor signaling pathway 8 364% 2E-02 2.786 0.881 32.638 
GO:0045746 negative regulation of Notch signaling pathway 3 136% 4E-02 9.870 0.943 44.083 
GO:0070098 chemokine-mediated signaling pathway 4 182% 4E-02 5.375 0.937 45.425 
GO:0002474 antigen processing and presentation of peptide 
antigen via MHC class I 
3 136% 4E-02 9.541 0.927 46.173 
GO:0034354 'de novo' NAD biosynthetic process from 
tryptophan 
2 91% 4E-02 47.705 0.925 48.090 
GO:0042127 regulation of cell proliferation 6 273% 5E-02 3.094 0.931 51.455 
GO:2001199 negative regulation of dendritic cell 
differentiation 
2 91% 5E-02 38.164 0.942 55.939 
GO:1900747 negative regulation of vascular endothelial 
growth factor signaling pathway 
2 91% 5E-02 38.164 0.942 55.939 
GO:0042060 wound healing 4 182% 5E-02 4.770 0.932 55.946 
GO:0008625 extrinsic apoptotic signaling pathway via death 
domain receptors 
3 136% 6E-02 7.532 0.950 61.670 
GO:2001237 negative regulation of extrinsic apoptotic 
signaling pathway 
3 136% 6E-02 7.532 0.950 61.670 
GO:0016311 dephosphorylation 4 182% 6E-02 4.438 0.945 62.536 
GO:0042742 defense response to bacterium 5 227% 6E-02 3.290 0.948 65.008 
GO:0002250 adaptive immune response 5 227% 7E-02 3.223 0.951 67.388 
GO:0030948 negative regulation of vascular endothelial 
growth factor receptor signaling pathway 
2 91% 7E-02 27.260 0.948 68.257 
GO:0019885 antigen processing and presentation of 
endogenous peptide antigen via MHC class I 
2 91% 7E-02 27.260 0.948 68.257 
GO:0072075 metanephric mesenchyme development 2 91% 8E-02 23.852 0.961 73.058 
GO:0055114 oxidation-reduction process 11 500% 9E-02 1.773 0.971 77.597 
GO:0021762 substantia nigra development 3 136% 9E-02 5.841 0.968 78.073 
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Table 5: DAVID analysis of molecular function GO terms 
Term Molecular Function Count % PValue Fold 
Enrichment 
Benjamini FDR 
GO:0016462 pyrophosphatase activity 3 136% 0.0022 41.106 0.5312 2.924 
GO:0005198 structural molecule activity 9 409% 0.0043 3.495 0.5277 5.708 
GO:0005506 iron ion binding 6 273% 0.0217 3.761 0.9218 25.882 
GO:0004872 receptor activity 7 318% 0.0257 3.094 0.8973 29.996 
GO:0051400 BH domain binding 2 91% 0.0508 38.366 0.9737 50.953 
GO:0043184 vascular endothelial growth factor receptor 2 
binding 
2 91% 0.0606 31.972 0.9737 57.467 
GO:0008307 structural constituent of muscle 3 136% 0.0703 6.851 0.9735 63.057 
GO:0042803 protein homodimerization activity 13 591% 0.0776 1.708 0.9706 66.868 
GO:0001517 N-acetylglucosamine 6-O-sulfotransferase 
activity 
2 91% 0.0800 23.979 0.9606 68.016 
GO:0045236 CXCR chemokine receptor binding 2 91% 0.0895 21.314 0.9621 72.265 
GO:0008009 chemokine activity 3 136% 0.0916 5.872 0.9526 73.115 
GO:0035591 signaling adaptor activity 2 91% 0.0990 19.183 0.9518 75.949 
 
 
Table 6: DAVID analysis of cellular component GO terms 
GO Term Cellular Component Count % PValue Fold 
Enrichment 
Benjamini FDR 
GO:0070062 extracellular exosome 61 2773% 3E-08 2.049063 5.62E-06 3.21E-05 
GO:0031225 anchored component of membrane 7 318% 1E-03 5.849328 0.131405 1.592973 
GO:0005886 plasma membrane 62 2818% 2E-03 1.420612 0.14521 2.646964 
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GO:0001725 stress fiber 5 227% 3E-03 8.743044 0.130963 3.14935 
GO:0031093 platelet alpha granule lumen 5 227% 3E-03 8.584079 0.113195 3.365325 
GO:0005615 extracellular space 26 1182% 4E-03 1.822603 0.140298 5.037981 
GO:0065010 extracellular membrane-bounded 
organelle 
2 91% 2E-02 94.42487 0.492304 23.69523 
GO:0030057 desmosome 3 136% 3E-02 11.80311 0.524186 28.726 
GO:0005882 intermediate filament 5 227% 3E-02 4.178092 0.550978 33.68116 
GO:0016021 integral component of membrane 67 3045% 4E-02 1.225347 0.586899 39.57997 
GO:0005856 cytoskeleton 9 409% 4E-02 2.29063 0.593968 43.16707 
GO:0005578 proteinaceous extracellular matrix 7 318% 6E-02 2.466321 0.71146 57.26042 
GO:0072562 blood microparticle 5 227% 8E-02 3.106081 0.749462 64.13883 
GO:0005576 extracellular region 24 1091% 8E-02 1.407576 0.748412 66.74824 
GO:0001533 cornified envelope 3 136% 8E-02 6.158144 0.732698 67.6293 

















Appendix C: WEBGESTALT upregulated GO Term analysis 
 
WEBGESTALT analysis of 281 upregulated genes resulted in 228 genes unnambiguously 
mapped to 228 unique entrezgene IDs. There were 53 genes which cannot be mapped to any 
entrezgene ID. 
FDR < 0.05 
 
Table 7: ID: GO:0036230; Name: granulocyte activation; size=500; overlap=22; expect=5.44; Enrichment 
Ratio=4.05; PValue=2.399e-8; FDR=2.039e-5 
Gene Symbol Gene Name Entrez Gene ID 
AOC1 amine oxidase, copper containing 1 26 
PGLYRP1 peptidoglycan recognition protein 1 8993 
SLC11A1 solute carrier family 11 member 1 6556 
FCGR2B Fc fragment of IgG receptor IIb 2213 
DSP desmoplakin 1832 
MMP9 matrix metallopeptidase 9 4318 
CTSZ cathepsin Z 1522 
RETN resistin 56729 
P2RX1 purinergic receptor P2X 1 5023 
VNN1 vanin 1 8876 
PADI2 peptidyl arginine deiminase 2 11240 
CHIT1 chitinase 1 1118 
ALDOA aldolase, fructose-bisphosphate A 226 
CDA cytidine deaminase 978 
PPBP pro-platelet basic protein 5473 
KRT1 keratin 1 3848 
FTH1 ferritin heavy chain 1 2495 
RNASE2 ribonuclease A family member 2 6036 
LOC102725035 undefined 102725035 
CD177 CD177 molecule 57126 
ORM1 orosomucoid 1 5004 
HP haptoglobin 3240 
 
Table 8: ID: GO:0050878; Name: regulation of body fluid levels; size=483; overlap=17; expect=5.25; 
Enrichment Ratio=3.24; PValue=2.046e-5; FDR=3.478e-3 
Gene 
Symbol 
Gene Name Entrez Gene ID 
CYP26B1 cytochrome P450 family 26 subfamily B member 1 56603 
CD9 CD9 molecule 928 
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ENTPD2 ectonucleoside triphosphate diphosphohydrolase 2 954 
GNA11 G protein subunit alpha 11 2767 
MYL9 myosin light chain 9 10398 
NEURL1 neuralized E3 ubiquitin protein ligase 1 9148 
P2RX1 purinergic receptor P2X 1 5023 
VWF von Willebrand factor 7450 
SH2B2 SH2B adaptor protein 2 10603 
TREML1 triggering receptor expressed on myeloid cells like 
1 
340205 
PF4 platelet factor 4 5196 
KRT1 keratin 1 3848 
GP9 glycoprotein IX platelet 2815 
PEAR1 platelet endothelial aggregation receptor 1 375033 
CD177 CD177 molecule 57126 
undefined hemoglobin subunit delta 3045 
ITGB3 integrin subunit beta 3 3690 
 
       
Table 9: ID: GO:0002576; Name: platelet degranulation; size=127; overlap=8; expect=1.38; Enrichment 
Ratio=5.79; PValue=7.353e-5; FDR=1.042e-2 
Gene 
Symbol 
Gene Name Entrez Gene ID 
CD9 CD9 molecule 928 
P2RX1 purinergic receptor P2X 1 5023 
VWF von Willebrand factor 7450 
ALDOA aldolase, fructose-bisphosphate A 226 
PPBP pro-platelet basic protein 5473 
PF4 platelet factor 4 5196 
ORM1 orosomucoid 1 5004 




Table 10: ID: GO:0006959; Name: humoral immune response; size=242; overlap=14; expect=2.63; 
Enrichment Ratio=5.32; PValue=3.985e-7; FDR=1.129e-4 
Gene 
Symbol 
Gene Name Entrez Gene ID 
PGLYRP1 peptidoglycan recognition protein 1 8993 
SLC11A1 solute carrier family 11 member 1 6556 
FCGR2B Fc fragment of IgG receptor IIb 2213 
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PI3 peptidase inhibitor 3 5266 
JCHAIN joining chain of multimeric IgA and IgM 3512 
SPON2 spondin 2 10417 
CXCL5 C-X-C motif chemokine ligand 5 6374 
PPBP pro-platelet basic protein 5473 
PF4 platelet factor 4 5196 
KRT1 keratin 1 3848 
RNASE2 ribonuclease A family member 2 6036 
C1QA complement C1q A chain 712 
SPNS2 sphingolipid transporter 2 124976 
DEFA3 defensin alpha 3 1668 
 
 




Gene Name Entrez Gene ID 
CD9 CD9 molecule 928 
ENTPD2 ectonucleoside triphosphate diphosphohydrolase 2 954 
GNA11 G protein subunit alpha 11 2767 
MYL9 myosin light chain 9 10398 
P2RX1 purinergic receptor P2X 1 5023 
VWF von Willebrand factor 7450 
SH2B2 SH2B adaptor protein 2 10603 
TREML1 triggering receptor expressed on myeloid cells like 
1 
340205 
PF4 platelet factor 4 5196 
KRT1 keratin 1 3848 
GP9 glycoprotein IX platelet 2815 
PEAR1 platelet endothelial aggregation receptor 1 375033 
CD177 CD177 molecule 57126 
undefined hemoglobin subunit delta 3045 
ITGB3 integrin subunit beta 3 3690 
 
 
Table 12: ID: GO:0002446; Name: neutrophil mediated immunity; size=496; overlap=21; expect=5.39; 
Enrichment Ratio=3.89; P Value=9.877e-8; FDR=4.198e-5 
Gene Symbol Gene Name Entrez Gene ID 
AOC1 amine oxidase, copper containing 1 26 
PGLYRP1 peptidoglycan recognition protein 1 8993 
SLC11A1 solute carrier family 11 member 1 6556 
DSP desmoplakin 1832 
MMP9 matrix metallopeptidase 9 4318 
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CTSZ cathepsin Z 1522 
RETN resistin 56729 
P2RX1 purinergic receptor P2X 1 5023 
VNN1 vanin 1 8876 
PADI2 peptidyl arginine deiminase 2 11240 
CHIT1 chitinase 1 1118 
ALDOA aldolase, fructose-bisphosphate A 226 
CDA cytidine deaminase 978 
PPBP pro-platelet basic protein 5473 
KRT1 keratin 1 3848 
FTH1 ferritin heavy chain 1 2495 
RNASE2 ribonuclease A family member 2 6036 
LOC102725035 undefined 102725035 
CD177 CD177 molecule 57126 
ORM1 orosomucoid 1 5004 
HP haptoglobin 3240 
 
 
Appendix D: WEBGESTALT downregulated GO Term analysis 
 
WEBGESTALT analysis of 161 downregulated genes resulted in 108 genes unnambiguously 
mapped to 108 unique entrezgene IDs. There were 61 genes which cannot be mapped to any 
entrezgene ID. 
 
Table 13: ID: GO:0034341; Name: response to interferon-gamma; size=192; overlap=9; expect=0.91; 
Enrichment Ratio=9.89; PValue=3.044e-7; FDR=1.384e-3 
Gene Symbol Gene Name Entrez Gene ID 
MT2A metallothionein 2A 4502 
HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 3119 
IFITM2 interferon induced transmembrane protein 2 10581 
HLA-DRB1 major histocompatibility complex, class II, DR beta 1 3123 
HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 3117 
HLA-DRB5 major histocompatibility complex, class II, DR beta 5 3127 
HLA-F major histocompatibility complex, class I, F 3134 
HLA-DPB1 major histocompatibility complex, class II, DP beta 1 3115 
CCL5 C-C motif chemokine ligand 5 6352 
 
 
Table 14: ID: GO:0002449; Name: lymphocyte mediated immunity; size=238; overlap=8; expect=1.13; 
Enrichment Ratio=7.09; PValue=1.676e-5; FDR=1.693e-2 
Gene Symbol Gene Name Entrez Gene ID 
TBX21 T-box 21 30009 
GZMB granzyme B 3002 
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KLRD1 killer cell lectin like receptor D1 3824 
CD8A CD8a molecule 925 
HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 3119 
PRF1 perforin 1 5551 
GZMM granzyme M 3004 
HLA-F major histocompatibility complex, class I, F 3134 
 
 
Table 15: ID: GO:0060333; Name: interferon-gamma-mediated signaling pathway; size=86; overlap=7; 
expect=0.41; Enrichment Ratio=1n7.17; PValue=1.632e-7; FDR=1.384e-3  
Gene Symbol Gene Name Entrez Gene ID 
MT2A metallothionein 2A 4502 
HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 3119 
HLA-DRB1 major histocompatibility complex, class II, DR beta 1 3123 
HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 3117 
HLA-DRB5 major histocompatibility complex, class II, DR beta 5 3127 
HLA-F major histocompatibility complex, class I, F 3134 





Table 16: ID: GO:0045087; Name: innate immune response; size=827; overlap=16; expect=3.92; Enrichment 
Ratio=4.08; PValue=1.335e-6; FDR=2.781e-3 
Gene Symbol Gene Name Entrez Gene ID 
APOBEC3H apolipoprotein B mRNA editing enzyme catalytic 
subunit 3H 
164668 
GZMB granzyme B 3002 
MT2A metallothionein 2A 4502 
KLRD1 killer cell lectin like receptor D1 3824 
S100B S100 calcium binding protein B 6285 
ZNF683 zinc finger protein 683 257101 
HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 3119 
APOBEC3B apolipoprotein B mRNA editing enzyme catalytic 
subunit 3B 
9582 
IFITM2 interferon induced transmembrane protein 2 10581 
HLA-DRB1 major histocompatibility complex, class II, DR beta 1 3123 
HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 3117 
GZMM granzyme M 3004 
HLA-DRB5 major histocompatibility complex, class II, DR beta 5 3127 
HLA-F major histocompatibility complex, class I, F 3134 
HLA-DPB1 major histocompatibility complex, class II, DP beta 1 3115 
CCL5 C-C motif chemokine ligand 5 6352 
 
